{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":15,"items":[{"indexed":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:55:38Z","timestamp":1574279738521},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1055\/s-0029-1192035","type":"journal-article","created":{"date-parts":[[2009,2,10]],"date-time":"2009-02-10T01:48:12Z","timestamp":1234230492000},"page":"559-562","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Strontium Ranelate on Lumbar Spine Bone Mineral Density in Women with Established Osteoporosis Previously Treated with Teriparatide"],"prefix":"10.1055","volume":"41","author":[{"given":"A.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"S.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"A.","family":"Avramidis","sequence":"additional","affiliation":[]},{"given":"A.","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"E.","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"194","published-online":{"date-parts":[[2009,2,9]]},"container-title":["Hormone and Metabolic Research"],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0029-1192035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T21:32:31Z","timestamp":1495488751000},"score":1.0,"issued":{"date-parts":[[2009,2,9]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2009,7]]},"issue":"07"},"URL":"http:\/\/dx.doi.org\/10.1055\/s-0029-1192035","ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T22:17:20Z","timestamp":1574288240697},"reference-count":53,"publisher":"Wiley","issue":"6","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":2283,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn. Cytopathol."],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1002\/dc.21055","type":"journal-article","created":{"date-parts":[[2009,3,20]],"date-time":"2009-03-20T20:49:36Z","timestamp":1237582176000},"page":"455-465","source":"Crossref","is-referenced-by-count":19,"title":["Histological alterations following thyroid fine needle biopsy: A systematic review"],"prefix":"10.1002","volume":"37","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Kalliopi","family":"Patsiaoura","sequence":"additional","affiliation":[]},{"given":"Konstantia","family":"Zachou","sequence":"additional","affiliation":[]}],"member":"311","reference":[{"key":"10.1002\/dc.21055-BIB1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4158\/EP.12.1.63","article-title":"AACE\/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules","volume":"12","author":"Gharib","year":"2006","journal-title":"Endocr Pract"},{"key":"10.1002\/dc.21055-BIB2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","article-title":"Management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"16","author":"Cooper","year":"2006","journal-title":"Thyroid"},{"key":"10.1002\/dc.21055-BIB3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1002\/dc.21055-BIB4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1081\/CNV-200027160","article-title":"Fine needle aspiration","volume":"22","author":"Wu","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1002\/dc.21055-BIB5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14310\/horm.2002.111107","article-title":"Thyroid nodules-Stepwise diagnosis and management","volume":"6","author":"Polyzos","year":"2007","journal-title":"Hormones"},{"key":"10.1002\/dc.21055-BIB6","author":"Polyzos","year":"2009","article-title":"Clinical Complications following thyroid fine needle biopsy: A systematic review","journal-title":"Clin Endocrinol","DOI":"10.1111\/j.1365-2265.2009.03522.x","doi-asserted-by":"crossref"},{"key":"10.1002\/dc.21055-BIB7","first-page":"99","article-title":"Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT)","volume":"29","author":"LiVolsi","year":"1994","journal-title":"Pathol Annu"},{"key":"10.1002\/dc.21055-BIB8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.prp.2007.05.004","article-title":"Histopathological changes in thyroid tissue after fine needle aspiration biopsy","volume":"203","author":"Bolat","year":"2007","journal-title":"Pathol Res Pract"},{"key":"10.1002\/dc.21055-BIB9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/ajcp\/112.3.311","article-title":"Post fine-needle aspiration histologic alterations of thyroid revisited","volume":"112","author":"Baloch","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/dc.21055-BIB10","first-page":"904","article-title":"Robustness of empirical search strategies for clinical content in MEDLINE","volume":"5","author":"Wilczynski","year":"2002","journal-title":"Proc AMIA Symp"},{"key":"10.1002\/dc.21055-BIB11","first-page":"456","article-title":"Tissue damage after fine needle aspiration biopsy","volume":"36","author":"Us-Krasovec","year":"1992","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00125480-199603000-00001","article-title":"Histologic changes induced by fine-needle aspiration","volume":"3","author":"Chan","year":"1996","journal-title":"Adv Anat Pathol"},{"key":"10.1002\/dc.21055-BIB13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1097-0339(199703)16:3<230::AID-DC7>3.0.CO;2-J","article-title":"Histologic alterations in the thyroid gland after fine-needle aspiration","volume":"16","author":"Ersoz","year":"1997","journal-title":"Diagn Cytopathol"},{"key":"10.1002\/dc.21055-BIB14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000327273","article-title":"Worrisome histologic alterations following fine needle aspiration of the thyroid","volume":"45","author":"Pandit","year":"2001","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB15","first-page":"83","article-title":"Secondary changes in the thyroid gland induced by aspiration cytology","volume":"38","author":"Ryska","year":"2002","journal-title":"Cesk Patol"},{"key":"10.1002\/dc.21055-BIB16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000325435","article-title":"Histologic analysis and comparison of techniques in fine needle aspiration-induced alterations in thyroid","volume":"52","author":"Sharma","year":"2008","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1078\/0344-0338-00285","article-title":"Focal sarcoid-like change of the thyroid gland. A possible consequence of aspiration cytology?","volume":"198","author":"Ludvikova","year":"2002","journal-title":"Pathol Res Pract"},{"key":"10.1002\/dc.21055-BIB18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/80.3.399","article-title":"Spontaneous disappearance of an atypical Hurthle cell adenoma","volume":"80","author":"Bauman","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/dc.21055-BIB19","first-page":"29","article-title":"Necrosis of thyroid nodules after fine needle aspiration","volume":"29","author":"Jones","year":"1985","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB20","first-page":"591","article-title":"Infarction of thyroid neoplasms following aspiration biopsy","volume":"30","author":"Kini","year":"1986","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB21","first-page":"940","article-title":"Infarction of thyroid nodule: A rare complication following fine needle aspiration","volume":"33","author":"Jayaram","year":"1989","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB22","first-page":"805","article-title":"Necrosis of a Hurthle cell tumor of the thyroid following fine needle aspiration. Case report and literature review","volume":"34","author":"Keyhani-Rofagha","year":"1990","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB23","first-page":"478","article-title":"Infarction of a papillary thyroid carcinoma after fine needle aspiration","volume":"35","author":"Alejo","year":"1991","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB24","first-page":"427","article-title":"Necrosis in thyroid nodules after fine needle aspiration biopsy. Report of two cases","volume":"35","author":"Layfield","year":"1991","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB25","first-page":"651","article-title":"Effect of fine needle aspiration biopsy on the histology of thyroid neoplasms","volume":"37","author":"Gordon","year":"1993","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2303.1995.tb00476.x","article-title":"Fine needle aspiration (FNA)-induced necrosis of tumours of the thyroid","volume":"6","author":"Ramp","year":"1995","journal-title":"Cytopathology"},{"key":"10.1002\/dc.21055-BIB27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1097-0339(199609)15:3<211::AID-DC7>3.0.CO;2-J","article-title":"Post-fine-needle biopsy infarction of thyroid neoplasms: A review of 28 cases","volume":"15","author":"Kini","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1002\/dc.21055-BIB28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1159\/000333949","article-title":"Infarction after fine needle aspiration. A report of four cases","volume":"40","author":"Pinto","year":"1996","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB29","first-page":"1307","article-title":"Infarction of a thyroid nodule after fine needle aspiration biopsy","volume":"42","author":"Pandit","year":"1998","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0046-8177(99)90071-0","article-title":"Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors","volume":"30","author":"Judkins","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1002\/dc.21055-BIB31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000325936","article-title":"Secondary infection and ischemic necrosis after fine needle aspiration for a painful papillary thyroid carcinoma: A case report","volume":"50","author":"Chen","year":"2006","journal-title":"Acta Cytol"},{"key":"10.1002\/dc.21055-BIB32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2006.16.697","article-title":"Transient vocal cord paralysis after fine-needle aspiration biopsy of thyroid tumor","volume":"16","author":"Tomoda","year":"2006","journal-title":"Thyroid"},{"key":"10.1002\/dc.21055-BIB33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0339(199605)14:4<362::AID-DC15>3.0.CO;2-I","article-title":"Cytology of the thyroid gland: Pitfalls in aspiration of the fibrotic nodule","volume":"14","author":"Van Hoeven","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1002\/dc.21055-BIB34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0339(199710)17:4<295::AID-DC11>3.0.CO;2-J","article-title":"Capsular pseudoinvasion after fine-needle aspiration of follicular adenomas of the thyroid","volume":"17","author":"Vercelli-Retta","year":"1997","journal-title":"Diagn Cytopathol"},{"key":"10.1002\/dc.21055-BIB35","first-page":"240","article-title":"Papillary endothelial hyperplasia in the thyroid following fine-needle aspiration","volume":"115","author":"Axiotis","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1002\/dc.21055-BIB36","first-page":"1040","article-title":"Vascular proliferation of the thyroid","volume":"116","author":"Tsang","year":"1992","journal-title":"A complication of fine-needle aspiration Arch Pathol Lab Med"},{"key":"10.1002\/dc.21055-BIB37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2559.1995.tb00254.x","article-title":"Intranodular reactive endothelial hyperplasia in adenomatous goitre","volume":"26","author":"Sapino","year":"1995","journal-title":"Histopathology"},{"key":"10.1002\/dc.21055-BIB38","first-page":"98","article-title":"Histological changes mimicking papillary carcinoma following fine needle aspiration of the thyroid gland","volume":"44","author":"Lopez","year":"1996","journal-title":"Arch Anat Cytol Pathol"},{"key":"10.1002\/dc.21055-BIB39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ajcp\/111.1.70","article-title":"Post-fine-needle aspiration spindle cell nodules of the thyroid (PSCNT)","volume":"111","author":"Baloch","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1002\/dc.21055-BIB40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.10.4.353","article-title":"American Association of Clinical Endocrinologists Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines","volume":"10","author":"Mechanick","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1002\/dc.21055-BIB41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.mlg.0000187396.18016.d0","article-title":"Intrathyroid hemorrhage and acute upper airway obstruction after fine needle aspiration of the thyroid gland","volume":"116","author":"Roh","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1002\/dc.21055-BIB42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2007.0363","article-title":"Bilateral thyroid hematomas after fine-needle aspiration causing acute airway obstruction","volume":"18","author":"Hor","year":"2008","journal-title":"Thyroid"},{"key":"10.1002\/dc.21055-BIB43","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00003072-199306000-00007","article-title":"The effect of fine-needle aspiration biopsy on the thyroid scan","volume":"18","author":"Gordon","year":"1993","journal-title":"Clin Nucl Med"},{"key":"10.1002\/dc.21055-BIB44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-96-2-221","article-title":"The thyroid nodule","volume":"96","author":"Van Herle","year":"1982","journal-title":"Ann Int Med"},{"key":"10.1002\/dc.21055-BIB45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12022-008-9039-x","article-title":"Diagnostic controversies in vascular proliferations of the thyroid gland","volume":"19","author":"Papotti","year":"2008","journal-title":"Endocr Pathol"},{"key":"10.1002\/dc.21055-BIB46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.crad.2007.01.024","article-title":"Sonographically guided fine-needle biopsy of thyroid nodules: The effects of nodule characteristics, sampling technique, and needle size on the adequacy of cytological material","volume":"62","author":"Degirmenci","year":"2007","journal-title":"Clin Radiol"},{"key":"10.1002\/dc.21055-BIB47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1479-666X(05)80091-5","article-title":"A comparative study of fine needle aspiration cytology versus non-aspiration technique in thyroid lesions","volume":"3","author":"Rizvi","year":"2005","journal-title":"Surgeon"},{"key":"10.1002\/dc.21055-BIB48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4158\/EP.10.3.242","article-title":"Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules and multinodular goiters","volume":"10","author":"Baskin","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1002\/dc.21055-BIB49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/dc.20828","article-title":"Training, credentialing and re-credentialing for the performance of a thyroid FNA: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference","volume":"36","author":"Ljung","year":"2008","journal-title":"Diagn Cytopathol"},{"key":"10.1002\/dc.21055-BIB50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF03344972","article-title":"Morphological changes in a hyperfunctioning thyroid adenoma after percutaneous ethanol injection: histological, enzymatic and sub-microscopical alterations","volume":"19","author":"Crescenzi","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1002\/dc.21055-BIB51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MED.0b013e32830eb89a","article-title":"Percutaneous laser ablation of benign and malignant thyroid nodules","volume":"15","author":"Papini","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1002\/dc.21055-BIB52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1600-0463.2002.100208.x","article-title":"Histologic changes in thyroid nodules after percutaneous ethanol injection in patients subsequently operated on due to new focal thyroid lesions","volume":"110","author":"Pomorski","year":"2002","journal-title":"APMIS"},{"key":"10.1002\/dc.21055-BIB53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiology.217.3.r00dc09673","article-title":"Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study","volume":"217","author":"Pacella","year":"2000","journal-title":"Radiology"}],"container-title":["Diagnostic Cytopathology"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdc.21055","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/dc.21055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T20:27:27Z","timestamp":1550521647000},"score":1.0,"editor":[{"given":"Zubair","family":"Baloch","sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2009,6]]},"references-count":53,"journal-issue":{"published-print":{"date-parts":[[2009,6]]},"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1002\/dc.21055","relation":{"cites":[]},"ISSN":["8755-1039","1097-0339"],"issn-type":[{"value":"8755-1039","type":"print"},{"value":"1097-0339","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T23:15:35Z","timestamp":1574291735440},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMM"],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.2174\/156652409787847191","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:54:48Z","timestamp":1238547288000},"page":"299-314","source":"Crossref","is-referenced-by-count":159,"title":["Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines"],"prefix":"10.2174","volume":"9","author":[{"given":"Stergios","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]}],"member":"965","container-title":["Current Molecular Medicine"],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/68916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T08:25:04Z","timestamp":1448267104000},"score":1.0,"issued":{"date-parts":[[2009,4,1]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2009,4,1]]},"issue":"3"},"alternative-id":["LiveAll1"],"URL":"http:\/\/dx.doi.org\/10.2174\/156652409787847191","ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T04:01:03Z","timestamp":1574308863433},"reference-count":205,"publisher":"Informa Healthcare","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1517\/13543780903048929","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T05:43:17Z","timestamp":1246254197000},"page":"1085-1102","source":"Crossref","is-referenced-by-count":19,"title":["RANKL inhibition for the management of patients with benign metabolic bone disorders"],"prefix":"10.1517","volume":"18","author":[{"given":"Athanasios D","family":"Anastasilakis","sequence":"first","affiliation":[{"name":"Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece"}]},{"given":"Konstantinos A","family":"Toulis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece"}]},{"given":"Stergios A","family":"Polyzos","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki School of Medicine, Second Department of Medicine, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[{"name":"University of Athens School of Medicine, Department of Clinical Therapeutics, 5 Marathonomahon street, Drosia Attikis, 14572, Greece ; ;"}]}],"member":"3197","published-online":{"date-parts":[[2009,6,28]]},"reference":[{"key":"CIT0001","DOI":"10.1016\/S0140-6736(06)68891-0","doi-asserted-by":"publisher"},{"key":"CIT0002","DOI":"10.1359\/jbmr.2003.18.6.1139","doi-asserted-by":"publisher"},{"key":"CIT0003","DOI":"10.1007\/s11914-008-0007-7","doi-asserted-by":"publisher"},{"key":"CIT0004","DOI":"10.1210\/er.19.1.80","doi-asserted-by":"publisher"},{"key":"CIT0005","author":"Roodman","volume":"17","first-page":"308","year":"1996","journal-title":"Endocr Rev"},{"key":"CIT0006","DOI":"10.1359\/jbmr.2000.15.9.1766","doi-asserted-by":"publisher"},{"key":"CIT0007","DOI":"10.1038\/16852","doi-asserted-by":"publisher"},{"key":"CIT0008","DOI":"10.1001\/jama.292.4.490","doi-asserted-by":"publisher"},{"key":"CIT0009","DOI":"10.1016\/S0092-8674(00)80209-3","doi-asserted-by":"publisher"},{"key":"CIT0010","DOI":"10.1101\/gad.13.18.2412","doi-asserted-by":"publisher"},{"key":"CIT0011","DOI":"10.1101\/gad.12.9.1260","doi-asserted-by":"publisher"},{"key":"CIT0012","DOI":"10.1038\/36593","doi-asserted-by":"publisher"},{"key":"CIT0013","DOI":"10.1084\/jem.186.12.2075","doi-asserted-by":"publisher"},{"key":"CIT0014","DOI":"10.1038\/46303","doi-asserted-by":"publisher"},{"key":"CIT0015","author":"Yun","volume":"161","first-page":"6113","year":"1998","journal-title":"J Immunol"},{"key":"CIT0016","DOI":"10.1084\/jem.189.7.1025","doi-asserted-by":"publisher"},{"key":"CIT0017","DOI":"10.1074\/jbc.M010153200","doi-asserted-by":"publisher"},{"key":"CIT0018","DOI":"10.1007\/s00125-004-1652-8","doi-asserted-by":"publisher"},{"key":"CIT0019","DOI":"10.1210\/jc.2003-031432","doi-asserted-by":"publisher"},{"key":"CIT0020","DOI":"10.1161\/hq1201.100229","doi-asserted-by":"publisher"},{"key":"CIT0021","DOI":"10.1084\/jem.192.4.463","doi-asserted-by":"publisher"},{"key":"CIT0022","DOI":"10.1161\/hq1001.097102","doi-asserted-by":"publisher"},{"key":"CIT0023","DOI":"10.1074\/jbc.C000290200","doi-asserted-by":"publisher"},{"key":"CIT0024","DOI":"10.1210\/jc.2005-0794","doi-asserted-by":"publisher"},{"key":"CIT0025","author":"Chen","volume":"47","first-page":"747","year":"2001","journal-title":"Clin Chem"},{"key":"CIT0026","DOI":"10.1172\/JCI200317215","doi-asserted-by":"publisher"},{"key":"CIT0027","DOI":"10.1056\/NEJM199502023320506","doi-asserted-by":"publisher"},{"key":"CIT0028","DOI":"10.1002\/jcb.20201","doi-asserted-by":"publisher"},{"key":"CIT0029","DOI":"10.1210\/en.2003-1536","doi-asserted-by":"publisher"},{"key":"CIT0030","DOI":"10.1359\/jbmr.1999.14.4.518","doi-asserted-by":"publisher"},{"key":"CIT0031","DOI":"10.1007\/s00198-003-1437-9","doi-asserted-by":"publisher"},{"key":"CIT0032","DOI":"10.1210\/jc.2002-020396","doi-asserted-by":"publisher"},{"key":"CIT0033","DOI":"10.1007\/s00198-005-1844-1","doi-asserted-by":"publisher"},{"key":"CIT0034","DOI":"10.1016\/S8756-3282(03)00090-5","doi-asserted-by":"publisher"},{"key":"CIT0035","DOI":"10.1007\/s00774-003-0461-3","doi-asserted-by":"publisher"},{"key":"CIT0036","DOI":"10.1007\/s00198-004-1699-x","doi-asserted-by":"publisher"},{"key":"CIT0037","DOI":"10.1007\/s001980200045","doi-asserted-by":"publisher"},{"key":"CIT0038","DOI":"10.1111\/j.1365-2265.2005.02221.x","doi-asserted-by":"publisher"},{"key":"CIT0039","DOI":"10.1001\/jama.291.9.1108","doi-asserted-by":"publisher"},{"key":"CIT0040","DOI":"10.1007\/s00223-004-0007-2","doi-asserted-by":"publisher"},{"key":"CIT0041","DOI":"10.1111\/j.1365-2265.2004.02179.x","doi-asserted-by":"publisher"},{"key":"CIT0042","DOI":"10.1111\/j.1365-2265.2006.02522.x","doi-asserted-by":"publisher"},{"key":"CIT0043","DOI":"10.1007\/BF03040334","doi-asserted-by":"publisher"},{"key":"CIT0044","DOI":"10.1210\/jcem.86.2.7186","doi-asserted-by":"publisher"},{"key":"CIT0045","DOI":"10.1172\/JCI2799","doi-asserted-by":"publisher"},{"key":"CIT0046","author":"Hofbauer","volume":"140","first-page":"4382","year":"1999","journal-title":"Endocrinology","DOI":"10.1210\/endo.140.10.7034","doi-asserted-by":"crossref"},{"key":"CIT0047","DOI":"10.1016\/S8756-3282(02)00742-1","doi-asserted-by":"publisher"},{"key":"CIT0048","DOI":"10.1097\/00042737-200311000-00003","doi-asserted-by":"publisher"},{"key":"CIT0049","DOI":"10.1359\/jbmr.2001.16.6.1004","doi-asserted-by":"publisher"},{"key":"CIT0050","author":"Rogers","volume":"18","first-page":"S280","year":"2003","journal-title":"J Bone Miner Res"},{"key":"CIT0051","DOI":"10.1007\/s00223-004-0126-9","doi-asserted-by":"publisher"},{"key":"CIT0052","DOI":"10.1359\/JBMR.0301226","doi-asserted-by":"publisher"},{"key":"CIT0053","author":"Lee","volume":"140","first-page":"3552","year":"1999","journal-title":"Endocrinology","DOI":"10.1210\/endo.140.8.6887","doi-asserted-by":"crossref"},{"key":"CIT0054","DOI":"10.1359\/jbmr.2002.17.9.1667","doi-asserted-by":"publisher"},{"key":"CIT0055","DOI":"10.1016\/j.jnutbio.2006.03.002","doi-asserted-by":"publisher"},{"key":"CIT0056","author":"Ma","volume":"142","first-page":"4047","year":"2001","journal-title":"Endocrinology","DOI":"10.1210\/endo.142.9.8356","doi-asserted-by":"crossref"},{"key":"CIT0057","DOI":"10.1002\/jcb.10623","doi-asserted-by":"publisher"},{"key":"CIT0058","DOI":"10.1016\/j.bone.2004.03.012","doi-asserted-by":"publisher"},{"key":"CIT0059","DOI":"10.1007\/s00223-002-2100-8","doi-asserted-by":"publisher"},{"key":"CIT0060","DOI":"10.1530\/eje.0.1450199","doi-asserted-by":"publisher"},{"key":"CIT0061","DOI":"10.1210\/jc.2007-1645","doi-asserted-by":"publisher"},{"key":"CIT0062","DOI":"10.1159\/000095068","doi-asserted-by":"publisher"},{"key":"CIT0063","DOI":"10.1016\/j.bone.2004.04.021","doi-asserted-by":"publisher"},{"key":"CIT0064","DOI":"10.1089\/thy.2007.0166","doi-asserted-by":"publisher"},{"key":"CIT0065","DOI":"10.1002\/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z","doi-asserted-by":"publisher"},{"key":"CIT0066","DOI":"10.1093\/rheumatology\/40.6.623","doi-asserted-by":"publisher"},{"key":"CIT0067","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH672>3.0.CO;2-W","doi-asserted-by":"publisher"},{"key":"CIT0068","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","doi-asserted-by":"publisher"},{"key":"CIT0069","author":"Stolina","volume":"65","first-page":"139","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"CIT0070","DOI":"10.1359\/JBMR.050601","doi-asserted-by":"publisher"},{"key":"CIT0071","DOI":"10.1007\/s00296-004-0579-1","doi-asserted-by":"publisher"},{"key":"CIT0072","author":"Geusens","volume":"17","first-page":"S386","year":"2002","journal-title":"J Bone Miner Res"},{"key":"CIT0073","DOI":"10.1002\/art.21896","doi-asserted-by":"publisher"},{"key":"CIT0074","DOI":"10.1002\/art.10388","doi-asserted-by":"publisher"},{"key":"CIT0075","DOI":"10.1093\/rheumatology\/kel072","doi-asserted-by":"publisher"},{"key":"CIT0076","author":"Franck","volume":"31","first-page":"2236","year":"2004","journal-title":"J Rheumatol"},{"key":"CIT0077","DOI":"10.1172\/JCI200316069","doi-asserted-by":"publisher"},{"key":"CIT0078","DOI":"10.1002\/art.22941","doi-asserted-by":"publisher"},{"key":"CIT0079","DOI":"10.1002\/art.23638","doi-asserted-by":"publisher"},{"key":"CIT0080","DOI":"10.1016\/j.clinbiochem.2008.02.011","doi-asserted-by":"publisher"},{"key":"CIT0081","DOI":"10.1302\/0301-620X.83B6.10905","doi-asserted-by":"publisher"},{"key":"CIT0082","DOI":"10.2106\/JBJS.E.01038","doi-asserted-by":"publisher"},{"key":"CIT0083","DOI":"10.1016\/j.jhep.2005.05.034","doi-asserted-by":"publisher"},{"key":"CIT0084","DOI":"10.1111\/j.1478-3231.2007.01448.x","doi-asserted-by":"publisher"},{"key":"CIT0085","DOI":"10.1016\/S0168-8278(02)00435-X","doi-asserted-by":"publisher"},{"key":"CIT0086","DOI":"10.1111\/j.1478-3231.2005.01073.x","doi-asserted-by":"publisher"},{"key":"CIT0087","DOI":"10.1093\/alcalc\/agl004","doi-asserted-by":"publisher"},{"key":"CIT0088","DOI":"10.1055\/s-2006-944548","doi-asserted-by":"publisher"},{"key":"CIT0089","DOI":"10.1359\/JBMR.040319","doi-asserted-by":"publisher"},{"key":"CIT0090","DOI":"10.1097\/01.MIB.0000164015.60795.ca","doi-asserted-by":"publisher"},{"key":"CIT0091","DOI":"10.1136\/gut.2004.044370","doi-asserted-by":"publisher"},{"key":"CIT0092","DOI":"10.1111\/j.1365-2249.2004.02643.x","doi-asserted-by":"publisher"},{"key":"CIT0093","DOI":"10.1007\/s11914-996-0031-4","doi-asserted-by":"publisher"},{"key":"CIT0094","DOI":"10.1359\/jbmr.040113","doi-asserted-by":"publisher"},{"key":"CIT0095","DOI":"10.1007\/s00774-006-0728-6","doi-asserted-by":"publisher"},{"key":"CIT0096","DOI":"10.1046\/j.1365-2141.2003.04657.x","doi-asserted-by":"publisher"},{"key":"CIT0097","DOI":"10.1007\/s00277-006-0180-7","doi-asserted-by":"publisher"},{"key":"CIT0098","author":"Voskaridou","volume":"91","first-page":"1193","year":"2006","journal-title":"Haematologica"},{"key":"CIT0099","author":"Fahrleitner","volume":"114","first-page":"717","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"CIT0100","DOI":"10.1053\/ajkd.2001.27437","doi-asserted-by":"publisher"},{"key":"CIT0101","DOI":"10.1016\/S8756-3282(02)00926-2","doi-asserted-by":"publisher"},{"key":"CIT0102","DOI":"10.1016\/j.bone.2006.06.011","doi-asserted-by":"publisher"},{"key":"CIT0103","DOI":"10.1093\/ndt\/17.2.233","doi-asserted-by":"publisher"},{"key":"CIT0104","DOI":"10.1053\/ajkd.2002.31402","doi-asserted-by":"publisher"},{"key":"CIT0105","DOI":"10.1007\/BF03350814","doi-asserted-by":"publisher"},{"key":"CIT0106","DOI":"10.1007\/BF03347242","doi-asserted-by":"publisher"},{"key":"CIT0107","author":"Grzegorzewska","volume":"21","first-page":"188","year":"2005","journal-title":"Adv Perit Dial"},{"key":"CIT0108","DOI":"10.1093\/ndt\/gfh672","doi-asserted-by":"publisher"},{"key":"CIT0109","DOI":"10.1007\/s002230001211","doi-asserted-by":"publisher"},{"key":"CIT0110","DOI":"10.1093\/qjmed\/95.4.233","doi-asserted-by":"publisher"},{"key":"CIT0111","DOI":"10.1002\/art.10834","doi-asserted-by":"publisher"},{"key":"CIT0112","DOI":"10.1016\/j.bone.2004.11.004","doi-asserted-by":"publisher"},{"key":"CIT0113","DOI":"10.1016\/j.bone.2006.08.003","doi-asserted-by":"publisher"},{"key":"CIT0114","DOI":"10.1359\/jbmr.080804","doi-asserted-by":"publisher"},{"key":"CIT0115","DOI":"10.1359\/jbmr.2003.18.2.376","doi-asserted-by":"publisher"},{"key":"CIT0116","DOI":"10.1359\/jbmr.2002.17.1.26","doi-asserted-by":"publisher"},{"key":"CIT0117","DOI":"10.1359\/jbmr.2003.18.8.1381","doi-asserted-by":"publisher"},{"key":"CIT0118","DOI":"10.1056\/NEJMoa013096","doi-asserted-by":"publisher"},{"key":"CIT0119","DOI":"10.1093\/hmg\/11.22.2735","doi-asserted-by":"publisher"},{"key":"CIT0120","author":"Hofbauer","volume":"140","first-page":"4367","year":"1999","journal-title":"Endocrinology","DOI":"10.1210\/endo.140.9.7131","doi-asserted-by":"crossref"},{"key":"CIT0121","DOI":"10.1210\/jc.2002-021877","doi-asserted-by":"publisher"},{"key":"CIT0122","DOI":"10.1007\/s00198-005-0035-4","doi-asserted-by":"publisher"},{"key":"CIT0123","DOI":"10.1007\/BF03346385","doi-asserted-by":"publisher"},{"key":"CIT0124","DOI":"10.1055\/s-2008-1046787","doi-asserted-by":"publisher"},{"key":"CIT0125","DOI":"10.1016\/j.bone.2008.01.010","doi-asserted-by":"publisher"},{"key":"CIT0126","DOI":"10.1210\/jc.2003-030891","doi-asserted-by":"publisher"},{"key":"CIT0127","DOI":"10.1210\/jcem.87.4.8397","doi-asserted-by":"publisher"},{"key":"CIT0128","DOI":"10.1016\/j.bone.2003.08.001","doi-asserted-by":"publisher"},{"key":"CIT0129","DOI":"10.1046\/j.1365-2265.2003.01969.x","doi-asserted-by":"publisher"},{"key":"CIT0130","DOI":"10.1677\/joe.0.1770423","doi-asserted-by":"publisher"},{"key":"CIT0131","DOI":"10.1016\/j.steroids.2005.04.011","doi-asserted-by":"publisher"},{"key":"CIT0132","DOI":"10.1016\/j.maturitas.2006.05.007","doi-asserted-by":"publisher"},{"key":"CIT0133","DOI":"10.1006\/bbrc.2002.6510","doi-asserted-by":"publisher"},{"key":"CIT0134","DOI":"10.1359\/jbmr.2004.19.1.147","doi-asserted-by":"publisher"},{"key":"CIT0135","DOI":"10.1038\/emm.2002.21","doi-asserted-by":"publisher"},{"key":"CIT0136","DOI":"10.1530\/eje.0.1480527","doi-asserted-by":"publisher"},{"key":"CIT0137","DOI":"10.1007\/s00198-005-0040-7","doi-asserted-by":"publisher"},{"key":"CIT0138","DOI":"10.1007\/s00198-008-0728-6","doi-asserted-by":"publisher"},{"key":"CIT0139","author":"Brennan","volume":"78","first-page":"S129","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"CIT0140","DOI":"10.1359\/jbmr.2002.17.5.808","doi-asserted-by":"publisher"},{"key":"CIT0141","DOI":"10.1359\/JBMR.040708","doi-asserted-by":"publisher"},{"key":"CIT0142","DOI":"10.1210\/jc.2003-032066","doi-asserted-by":"publisher"},{"key":"CIT0143","DOI":"10.1530\/EJE-07-0528","doi-asserted-by":"publisher"},{"key":"CIT0144","DOI":"10.1210\/er.2007-0014","doi-asserted-by":"publisher"},{"key":"CIT0145","DOI":"10.1359\/jbmr.2001.16.2.348","doi-asserted-by":"publisher"},{"key":"CIT0146","DOI":"10.1359\/jbmr.1999.14.9.1478","doi-asserted-by":"publisher"},{"key":"CIT0147","DOI":"10.1002\/cncr.11138","doi-asserted-by":"publisher"},{"key":"CIT0148","DOI":"10.1359\/jbmr.2003.18.5.852","doi-asserted-by":"publisher"},{"key":"CIT0149","DOI":"10.1007\/s00198-007-0363-7","doi-asserted-by":"publisher"},{"key":"CIT0150","DOI":"10.1038\/nature01658","doi-asserted-by":"publisher"},{"key":"CIT0151","DOI":"10.1359\/JBMR.040305","doi-asserted-by":"publisher"},{"key":"CIT0152","DOI":"10.1056\/NEJMoa044459","doi-asserted-by":"publisher"},{"key":"CIT0153","DOI":"10.1517\/13543776.18.11.1265","doi-asserted-by":"publisher"},{"key":"CIT0154","DOI":"10.4049\/jimmunol.175.9.6211","doi-asserted-by":"publisher"},{"key":"CIT0155","DOI":"10.1016\/j.bone.2003.12.006","doi-asserted-by":"publisher"},{"key":"CIT0156","DOI":"10.1359\/jbmr.060915","doi-asserted-by":"publisher"},{"key":"CIT0157","DOI":"10.1359\/jbmr.080109","doi-asserted-by":"publisher"},{"key":"CIT0158","author":"Kostenuik","year":"2009","journal-title":"J Bone Miner Res"},{"key":"CIT0159","author":"Ominsky","volume":"21","first-page":"S72","year":"2006","journal-title":"J Bone Miner Res"},{"key":"CIT0160","author":"Ominsky","volume":"22","first-page":"S23","year":"2007","journal-title":"J Bone Miner Res"},{"key":"CIT0161","DOI":"10.1359\/jbmr.2001.16.1.148","doi-asserted-by":"publisher"},{"key":"CIT0162","DOI":"10.1016\/j.bone.2005.08.009","doi-asserted-by":"publisher"},{"key":"CIT0163","DOI":"10.1007\/s00223-004-0028-x","doi-asserted-by":"publisher"},{"key":"CIT0164","DOI":"10.1002\/jor.20469","doi-asserted-by":"publisher"},{"key":"CIT0165","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res"},{"key":"CIT0166","DOI":"10.1016\/j.bone.2005.07.021","doi-asserted-by":"publisher"},{"key":"CIT0167","DOI":"10.1016\/S0002-9440(10)63016-7","doi-asserted-by":"publisher"},{"key":"CIT0168","DOI":"10.1007\/s00011-005-0005-5","doi-asserted-by":"publisher"},{"key":"CIT0169","DOI":"10.1016\/j.bone.2004.07.004","doi-asserted-by":"publisher"},{"key":"CIT0170","DOI":"10.1016\/S0002-9440(10)64417-3","doi-asserted-by":"publisher"},{"key":"CIT0171","DOI":"10.1007\/s00223-005-0161-1","doi-asserted-by":"publisher"},{"key":"CIT0172","DOI":"10.1359\/jbmr.060905","doi-asserted-by":"publisher"},{"key":"CIT0173","DOI":"10.1902\/jop.2007.070073","doi-asserted-by":"publisher"},{"key":"CIT0174","DOI":"10.1210\/jc.2007-2814","doi-asserted-by":"publisher"},{"key":"CIT0175","DOI":"10.1359\/jbmr.0809010","doi-asserted-by":"publisher"},{"key":"CIT0176","DOI":"10.1359\/jbmr.070809","doi-asserted-by":"publisher"},{"key":"CIT0177","DOI":"10.1007\/s00223-002-2011-8","doi-asserted-by":"publisher"},{"key":"CIT0178","DOI":"10.1001\/jama.282.14.1344","doi-asserted-by":"publisher"},{"key":"CIT0179","DOI":"10.1056\/NEJMoa011807","doi-asserted-by":"publisher"},{"key":"CIT0180","DOI":"10.1016\/j.jocd.2008.04.001","doi-asserted-by":"publisher"},{"key":"CIT0181","DOI":"10.1016\/j.bone.2008.04.007","doi-asserted-by":"publisher"},{"key":"CIT0182","author":"Anastasilakis","year":"2009","journal-title":"Horm Metab Res"},{"key":"CIT0183","author":"Cummings","volume":"23","first-page":"S80","year":"2008","journal-title":"J Bone Miner Res"},{"key":"CIT0184","DOI":"10.1200\/JCO.2008.16.3832","doi-asserted-by":"publisher"},{"key":"CIT0185","DOI":"10.1002\/art.23417","doi-asserted-by":"publisher"},{"key":"CIT0186","DOI":"10.4049\/jimmunol.179.11.7497","doi-asserted-by":"publisher"},{"key":"CIT0187","DOI":"10.1016\/j.clim.2003.09.001","doi-asserted-by":"publisher"},{"key":"CIT0188","DOI":"10.4049\/jimmunol.179.1.266","doi-asserted-by":"publisher"},{"key":"CIT0189","DOI":"10.1016\/1074-7613(95)90057-8","doi-asserted-by":"publisher"},{"key":"CIT0190","DOI":"10.1074\/jbc.273.23.14363","doi-asserted-by":"publisher"},{"key":"CIT0191","DOI":"10.1210\/jc.2004-0952","doi-asserted-by":"publisher"},{"key":"CIT0192","DOI":"10.1210\/jc.2007-2803","doi-asserted-by":"publisher"},{"key":"CIT0193","DOI":"10.1016\/S0736-0266(03)00011-1","doi-asserted-by":"publisher"},{"key":"CIT0194","DOI":"10.1007\/s00198-006-0322-8","doi-asserted-by":"publisher"},{"key":"CIT0195","DOI":"10.1185\/030079905X61875","doi-asserted-by":"publisher"},{"key":"CIT0196","DOI":"10.1359\/jbmr.2002.17.2.192","doi-asserted-by":"publisher"},{"key":"CIT0197","author":"Kostenuik","volume":"142","first-page":"4295","year":"2001","journal-title":"Endocrinology","DOI":"10.1210\/endo.142.10.8437","doi-asserted-by":"crossref"},{"key":"CIT0198","DOI":"10.1016\/S0140-6736(97)02342-8","doi-asserted-by":"publisher"},{"key":"CIT0199","DOI":"10.1056\/NEJMoa031975","doi-asserted-by":"publisher"},{"key":"CIT0200","DOI":"10.1359\/JBMR.050714","doi-asserted-by":"publisher"},{"key":"CIT0201","DOI":"10.1136\/ard.48.5.396","doi-asserted-by":"publisher"},{"key":"CIT0202","DOI":"10.1002\/art.21824","doi-asserted-by":"publisher"},{"key":"CIT0203","DOI":"10.1359\/jbmr.1997.12.7.1058","doi-asserted-by":"publisher"},{"key":"CIT0204","DOI":"10.1359\/jbmr.1999.14.1.21","doi-asserted-by":"publisher"},{"key":"CIT0205","DOI":"10.1359\/jbmr.2002.17.8.1452","doi-asserted-by":"publisher"}],"container-title":["Expert Opinion on Investigational Drugs"],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543780903048929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:21:08Z","timestamp":1536250868000},"score":1.0,"issued":{"date-parts":[[2009,6,28]]},"references-count":205,"journal-issue":{"published-online":{"date-parts":[[2009,7]]},"published-print":{"date-parts":[[2009,8]]},"issue":"8"},"alternative-id":["10.1517\/13543780903048929"],"URL":"http:\/\/dx.doi.org\/10.1517\/13543780903048929","relation":{"cites":[]},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T05:39:18Z","timestamp":1574314758438},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00520-009-0704-5","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T06:12:22Z","timestamp":1248847942000},"page":"1329-1330","source":"Crossref","is-referenced-by-count":6,"title":["Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid"],"prefix":"10.1007","volume":"17","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"704_CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00520-009-0591-9","volume":"17","author":"M Sayin","year":"2009","unstructured":"Sayin M, Yazici G (2009) Hyperparathyroidism secondary to zoledronic acid infusion: case report. Support Care Cancer 17:469\u2013470","journal-title":"Support Care Cancer"},{"key":"704_CR2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-008-0852-6","volume":"26","author":"A Avramidis","year":"2008","unstructured":"Avramidis A, Polyzos SA, Moralidis E et al (2008) Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone. J Bone Miner Metab 26:635\u2013641","journal-title":"J Bone Miner Metab"},{"key":"704_CR3","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou Z et al (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget's disease of bone. Horm Metab Res 4. doi: 10.1016\/j.bone.2009.03.520","DOI":"10.1016\/j.bone.2009.03.520","doi-asserted-by":"crossref"},{"key":"704_CR4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bone.2006.04.032","volume":"39","author":"HE Whitson","year":"2006","unstructured":"Whitson HE, Lobaugh B, Lyles KW (2006) Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone. Bone 39:954\u2013958","journal-title":"Bone"},{"key":"704_CR5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1359\/jbmr.2003.18.5.868","volume":"18","author":"SC Cremers","year":"2003","unstructured":"Cremers SC, Eekhoff ME, Den HJ, Hamdy NA, Vermeij P, Papapoulos SE (2003) Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone. J Bone Miner Res 18:868\u2013875","journal-title":"J Bone Miner Res"},{"key":"704_CR6","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Paget's disease of bone: a review with emphasis to treatment with zoledronic acid. Expert Rev Endocrinol Metab 4 (in press)","DOI":"10.1586\/eem.09.35","doi-asserted-by":"crossref"},{"key":"704_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.joms.2009.01.012","volume":"67","author":"B Mehrotra","year":"2009","unstructured":"Mehrotra B (2009) Bisphosphonates\u2014role in cancer therapies. J Oral Maxillofac Surg 67:19\u201326","journal-title":"J Oral Maxillofac Surg"},{"key":"704_CR8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","volume":"99","author":"K Nosaka","year":"2002","unstructured":"Nosaka K, Miyamoto T, Sakai T, Mitsuya H, Suda T, Matsuoka M (2002) Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood 99:634\u2013640","journal-title":"Blood"},{"key":"704_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14728220903025770","volume":"13","author":"M Gavriatopoulou","year":"2009","unstructured":"Gavriatopoulou M, Dimopoulos MA, Christoulas D et al (2009) Dickkopf-1: a suitable target for the management of myeloma bone disease. Expert Opin Ther Targets 13:839\u2013848","journal-title":"Expert Opin Ther Targets"},{"key":"704_CR10","first-page":"1383","volume":"82","author":"JF Seymour","year":"1993","unstructured":"Seymour JF, Gagel RF (1993) Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 82:1383\u20131394","journal-title":"Blood"}],"container-title":["Supportive Care in Cancer"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-009-0704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-009-0704-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-009-0704-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:54Z","timestamp":1559095314000},"score":1.0,"issued":{"date-parts":[[2009,7,30]]},"references-count":10,"journal-issue":{"published-print":{"date-parts":[[2009,10]]},"issue":"10"},"alternative-id":["704"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00520-009-0704-5","relation":{"cites":[]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T10:57:35Z","timestamp":1574333855630},"reference-count":193,"publisher":"Wiley","issue":"5","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1981,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1111\/j.1463-1326.2009.01176.x","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T08:46:07Z","timestamp":1257497167000},"page":"365-383","source":"Crossref","is-referenced-by-count":106,"title":["The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease"],"prefix":"10.1111","volume":"12","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Tsiaousi","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2559.2006.02416.x","article-title":"Histological assessment of non-alcoholic fatty liver disease","volume":"49","author":"Hubscher","year":"2006","journal-title":"Histopathology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.2008.03703.x","article-title":"Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease","volume":"28","author":"Barshop","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB6|cit6","unstructured":"Ford ES Giles WH Mokdad AH. 2004 27 2444 2449","DOI":"10.2337\/diacare.27.10.2444","doi-asserted-by":"crossref"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","article-title":"Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Choudhury","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB9|cit9","unstructured":"Wilczynski NL Haynes RB. Robustness of empirical search strategies for clinical content in MEDLINE. Proceedings of the AMIA Symposium 2002 904 908"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/17474124.2.5.705","article-title":"Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes","volume":"2","author":"Gronbaek","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","article-title":"Adipose tissue: the new endocrine organ? a review article","volume":"54","author":"Wozniak","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00535-008-2193-6","article-title":"Liver diseases and metabolic syndrome","volume":"43","author":"Watanabe","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB16|cit16","first-page":"1083","article-title":"Adipokine interrelationship with the liver","volume":"64","author":"Takei","year":"2006","journal-title":"Nippon Rinsho"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","article-title":"Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease","volume":"4","author":"Wong","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB22|cit22","first-page":"127","article-title":"The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease","volume":"13","author":"Polyzos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1210\/en.2007-1561","article-title":"Plasma adiponectin complexes have distinct biochemical characteristics","volume":"149","author":"Schraw","year":"2008","journal-title":"Endocrinology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.phrs.2007.09.014","article-title":"Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk","volume":"56","author":"Giannessi","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jhep.2005.08.019","article-title":"Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice","volume":"44","author":"Wolf","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/bbrc.2001.5134","article-title":"Change in expression of GBP28\/adiponectin in carbon tetrachloride-administrated mouse liver","volume":"285","author":"Yoda-Murakami","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic meta-bolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/er.2006-0033","article-title":"Adipose tissue-derived factors: impact on health and disease","volume":"27","author":"Trujillo","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1038\/oby.2007.291","article-title":"Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women","volume":"15","author":"Araneta","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2008-0425","article-title":"Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance","volume":"93","author":"Hivert","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB36|cit36","first-page":"20","article-title":"Adiponectin: lowering in metabolic syndrome and independent relation to hypertriglyceridemia","volume":"48","author":"Tanianskii","year":"2008","journal-title":"Kardiologiia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","volume":"27","author":"Shetty","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2143\/AC.63.2.2029522","article-title":"The association between plasma adiponectin level and hypertension","volume":"63","author":"Shankar","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1371\/journal.pone.0004733","article-title":"Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques","volume":"4","author":"Broedl","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MCA.0b013e3282f3c40b","article-title":"Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome","volume":"19","author":"Selcuk","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB43|cit43","first-page":"55","article-title":"Adiponectin and resistin-new hormones of white adipose tissue","volume":"9","author":"Beltowski","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase","volume":"47","author":"Adachi","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbrc.2006.09.101","article-title":"Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro","volume":"350","author":"Neumeier","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences","volume":"47","author":"Leclercq","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1742-4658.2009.06955.x","article-title":"Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH terminal kinase","volume":"276","author":"Jung","year":"2009","journal-title":"FEBS J"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/en.2004-1572","article-title":"Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin","volume":"146","author":"Sennello","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1152\/ajpendo.90731.2008","article-title":"APPL1: role in adiponectin signaling and beyond","volume":"296","author":"Deepa","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2004-2240","article-title":"Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity","volume":"90","author":"Bugianesi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/gut.2003.037010","article-title":"Adiponectin and its receptors in non-alcoholic steatohepatitis","volume":"54","author":"Kaser","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/j.1572-0241.2005.00297.x","article-title":"Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis","volume":"100","author":"Musso","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mcg.0000152747.79773.2f","article-title":"Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study","volume":"39","author":"Vuppalanchi","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.01821","article-title":"Plasma adiponectin is decreased in nonalcoholic fatty liver disease","volume":"152","author":"Pagano","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2006-1010","article-title":"Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat","volume":"91","author":"Burgert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.metabol.2007.06.013","article-title":"Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line","volume":"56","author":"Shimizu","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2007.01322.x","article-title":"Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7 S level to predict the early stage of nonalcoholic steatohepatitis","volume":"102","author":"Shimada","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","article-title":"A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB61|cit61","first-page":"355","article-title":"Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.","volume":"71","author":"Arvaniti","year":"2008","journal-title":"Acta Gastro-Enterol Belg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB62|cit62","first-page":"123","article-title":"Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis","volume":"8","author":"Munoz","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s10620-007-9981-3","article-title":"Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease","volume":"53","author":"Aller","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2006.02527.x","article-title":"Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/07853890801946515","article-title":"Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro\/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis","volume":"40","author":"Musso","year":"2008","journal-title":"Ann Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1440-1746.2008.05548.x","article-title":"Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease","volume":"24","author":"Ma","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB67|cit67","first-page":"67","article-title":"Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease","volume":"7","author":"Uribe","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1152\/ajpendo.00494.2003","article-title":"Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics","volume":"287","author":"Tietge","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2005.01543.x","article-title":"Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis","volume":"258","author":"Kaser","year":"2005","journal-title":"J Intern Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2004.0986.x","article-title":"Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels","volume":"25","author":"Sohara","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB71|cit71","author":"Polyzos","year":"2009","article-title":"Non-linear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","article-title":"Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis","volume":"103","author":"Floreani","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2004.12.024","article-title":"High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo","volume":"42","author":"Tacke","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1517\/14728220802658481","article-title":"Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology","volume":"13","author":"Beige","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nut.2008.07.020","article-title":"Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease","volume":"25","author":"Valentini","year":"2009","journal-title":"Nutrition"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.2008.095737","article-title":"Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis","volume":"68","author":"Filkova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10067-008-1074-y","article-title":"Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction","volume":"28","author":"Ebina","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.clinbiochem.2009.02.023","article-title":"Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure","volume":"42","author":"Dieplinger","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB79|cit79","author":"Celik","year":"2009","article-title":"Elevated adiponectin levels in patients with chronic heart failure: An independent predictor of mortality or a marker of cardiac cachexia?","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/eurjhf\/hfp046","article-title":"Adiponectin is increased in cardiac cachexia irrespective of body mass index","volume":"11","author":"Paulo","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.2003.02264.x","article-title":"Circulating adiponectin levels during human endotoxaemia","volume":"134","author":"Keller","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11695-008-9701-x","article-title":"Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis","volume":"19","author":"Nannipieri","year":"2009","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/hep.22142","article-title":"Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH","volume":"47","author":"Musso","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00535-009-0085-z","article-title":"Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease","volume":"44","author":"Tokushige","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/BF03345657","article-title":"Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population","volume":"31","author":"Wang","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1478-3231.2007.01623.x","article-title":"Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people","volume":"28","author":"Hui","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.22659","article-title":"Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH","volume":"49","author":"Musso","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2350-10-15","article-title":"Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis","volume":"10","author":"Tong","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.10.4.353","article-title":"American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines","volume":"10","author":"AACE Ad Hoc Task Force","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2007.03.020","article-title":"Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model","volume":"47","author":"Kamada","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/MCG.0b013e3181962de8","article-title":"Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction: An Epidemiologic Study of 3827 Japanese Subjects","volume":"43","author":"Kamada","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1381\/096089206778392149","article-title":"Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance","volume":"16","author":"Baranova","year":"2006","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ajcn\/87.2.295","article-title":"Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals","volume":"87","author":"Koska","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1210\/jc.2007-0187","article-title":"Postprandial lipemia associates with liver fat content","volume":"92","author":"Matikainen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","article-title":"Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease","volume":"42","author":"Musso","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0929-6646(09)60079-6","article-title":"The clinical implications of blood adiponectin in cardiometabolic disorders","volume":"108","author":"Chang","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2003.027086","article-title":"Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance","volume":"53","author":"Donati","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/HJH.0b013e32830dfe4b","article-title":"Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients","volume":"26","author":"Fallo","year":"2008","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/HJH.0b013e328317a7bb","article-title":"High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study","volume":"27","author":"Bo","year":"2009","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.jhh.1002148","article-title":"Hypertension and fatty liver: guilty by association?","volume":"21","author":"Brookes","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.metabol.2004.11.008","article-title":"Exercise training is not associated with improved levels of C-reactive protein or adiponectin","volume":"54","author":"Marcell","year":"2005","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.metabol.2007.03.009","article-title":"In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children","volume":"56","author":"Kelly","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3945\/ajcn.2008.26371","article-title":"Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study","volume":"89","author":"Jacobs","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJR.0b013e3282efaf50","article-title":"The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus","volume":"14","author":"Kadoglou","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.metabol.2005.01.033","article-title":"Effects of diet and\/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes","volume":"54","author":"Giannopoulou","year":"2005","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1464-5491.2005.01569.x","article-title":"Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes","volume":"22","author":"Hung","year":"2005","journal-title":"Diabet Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jnutbio.2007.05.007","article-title":"Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss","volume":"19","author":"Jung","year":"2008","journal-title":"J Nutr Biochem"},{"issue":"Suppl. 1","key":"10.1111\/j.1463-1326.2009.01176.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2003.12.008","article-title":"Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women","volume":"66","author":"Kim","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.metabol.2003.11.022","article-title":"Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines","volume":"53","author":"Valsamakis","year":"2004","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11695-008-9678-5","article-title":"GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism","volume":"19","author":"De Carvalho","year":"2009","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/jc.2007-1370","article-title":"Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin","volume":"93","author":"Garcia de la","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/db06-1161","article-title":"Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss","volume":"56","author":"Lin","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB122|cit122","first-page":"1266","article-title":"Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss","volume":"10","author":"Linscheid","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.soard.2008.08.013","article-title":"Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels","volume":"5","author":"Savu","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2006.05.005","article-title":"Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement","volume":"4","author":"Lutchman","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/diabetes.53.8.2169","article-title":"Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes","volume":"53","author":"Tiikkainen","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2265.2006.02658.x","article-title":"Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus","volume":"65","author":"Sharma","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2265.2006.02723.x","article-title":"Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus","volume":"66","author":"Kim","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2007.03.018","article-title":"Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus","volume":"56","author":"Hsieh","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1210\/jc.2005-1231","article-title":"Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes","volume":"91","author":"Hermann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1797.2007.00764.x","article-title":"Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome","volume":"12","author":"Yilmaz","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.HYP.0000078490.59735.6E","article-title":"Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension","volume":"42","author":"Furuhashi","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2710.2007.00820.x","article-title":"Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone","volume":"32","author":"Derosa","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1152\/ajpendo.00133.2006","article-title":"Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes","volume":"292","author":"Juurinen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.physbeh.2007.03.004","article-title":"Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations","volume":"91","author":"Lejeune","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2006.10.001","article-title":"The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects","volume":"17","author":"Albert","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/diabetes.54.8.2390","article-title":"Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial","volume":"54","author":"Wynne","year":"2005","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/HJH.0b013e328311cf37","article-title":"Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women","volume":"26","author":"Poyhonen-Alho","year":"2008","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.amjhyper.2005.05.026","article-title":"Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension","volume":"18","author":"Nowak","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1478-3231.2009.02037.x","article-title":"Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis","volume":"29","author":"Balmer","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOG.0b013e3283294a18","article-title":"Recent advances in nonalcoholic fatty liver disease","volume":"25","author":"Cheung","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0028-1091984","article-title":"Current and emerging therapies in nonalcoholic fatty liver disease","volume":"28","author":"Kashi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1478-3231.2007.01574.x","article-title":"Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period","volume":"27","author":"Nishide","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2004.02101.x","article-title":"Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers","volume":"61","author":"Wolfe","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/ENDO:26:1:065","article-title":"Lack of increase of serum adiponectin concentrations with a moderate weight loss during six months on a high-caloric diet in military service among a young male Finnish population","volume":"26","author":"Mousavinasab","year":"2005","journal-title":"Endocrine"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","article-title":"Diagnosis and therapy of nonalcoholic steatohepatitis","volume":"134","author":"Torres","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI25076","article-title":"Food for thought: endocannabinoid modulation of lipogenesis","volume":"115","author":"Lichtman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats","volume":"46","author":"Gary-Bobo","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2353\/ajpath.2008.070720","article-title":"Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis","volume":"173","author":"DeLeve","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","article-title":"CB2 receptors as new therapeutic targets for liver diseases","volume":"153","author":"Lotersztajn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079905X38132","article-title":"A review of the metabolic effects of sibutramine","volume":"21","author":"Filippatos","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB160|cit160","first-page":"189","article-title":"The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis","volume":"12","author":"Sabuncu","year":"2003","journal-title":"Rom J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB161|cit161","first-page":"364","article-title":"Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery","volume":"7","author":"De Andrade","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1111\/j.1463-1326.2009.01176.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferre","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists","volume":"281","author":"Nawrocki","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.21661","article-title":"The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis","volume":"46","author":"Lutchman","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330802597821","article-title":"How safe is the use of thiazolidinediones in clinical practice?","volume":"8","author":"Rizos","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","article-title":"Metformin in the treatment of patients with non-alcoholic steatohepatitis","volume":"19","author":"Uygun","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB174|cit174","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5448.2008.00450.x","article-title":"Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents","volume":"10","author":"Nadeau","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB175|cit175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses.","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB176|cit176","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2036.2006.02926.x","article-title":"A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients","volume":"23","author":"Gomez-Dominguez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB177|cit177","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB178|cit178","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-1241.2007.01666.x","article-title":"Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study","volume":"62","author":"Riley","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB179|cit179","first-page":"102","article-title":"PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes","volume":"23","author":"Seo","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB180|cit180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0168-8278(99)80243-8","article-title":"A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis","volume":"31","author":"Basaranoglu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB181|cit181","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1152\/ajpendo.00340.2006","article-title":"Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes","volume":"292","author":"Nakano","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB182|cit182","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia","volume":"14","author":"Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB183|cit183","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB184|cit184","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","article-title":"Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis","volume":"12","author":"Yokohama","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB185|cit185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2009.01.026","article-title":"Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model","volume":"206","author":"Rosselli","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB186|cit186","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.108.112292","article-title":"Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition","volume":"52","author":"Yamamoto","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB187|cit187","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1440-1681.2008.05129.x","article-title":"Angiotensin converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumor necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes","volume":"36","author":"Zhang","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB188|cit188","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1055\/s-2008-1027411","article-title":"Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH)","volume":"46","author":"Schramm","year":"2008","journal-title":"Z Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB189|cit189","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","article-title":"No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis","volume":"65","author":"Harle","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB190|cit190","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.mehy.2008.12.019","article-title":"Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways","volume":"72","author":"Polyzos","year":"2009","journal-title":"Med Hypotheses"},{"issue":"Suppl. 7","key":"10.1111\/j.1463-1326.2009.01176.x-BIB191|cit191","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/ijo.2008.235","article-title":"Gastrointestinal satiety signals","volume":"32","author":"Chaudhri","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB192|cit192","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MPG.0b013e31818e04d1","article-title":"Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review","volume":"48","author":"Socha","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB193|cit193","author":"Angelico","first-page":"CD005166","year":"2007","article-title":"Drugs improving insulin resistance for non-alcoholic fatty liver disease and\/or non-alcoholic steatohepatitis","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Diabetes, Obesity and Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2009.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T17:36:02Z","timestamp":1558632962000},"score":1.0,"issued":{"date-parts":[[2010,3,30]]},"references-count":193,"journal-issue":{"issue":"5"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1463-1326.2009.01176.x","relation":{"cites":[]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:21:23Z","timestamp":1574353283853},"reference-count":0,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The mechanisms regulating the anabolic response of the skeleton to intermittent exogenous parathyroid hormone (PTH) administration are not fully elucidated. The aim of this prospective study was to evaluate the acute effect (up to 1 month) of teriparatide (TPTD; human recombinant PTH 1\u201334) on serum levels of osteoprotegerin (OPG) and receptor activator for nuclear factor-\u03baB ligand (RANKL) in women with established osteoporosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Twenty-three postmenopausal Caucasian women with established osteoporosis (mean age 66.7\u00b11.6 years) received daily injections of 20\u200a\u03bcg TPTD for 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples for total calcium (Ca), phosphate, alkaline phosphatase, N-terminal propeptide of type I collagen, intact PTH (iPTH), OPG, and RANKL were obtained at baseline, 1\u200ah, 1 day, and 1 month after initiation of therapy. Lumbar spine bone mineral density (BMD) was measured before and 12 months after TPTD treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum total Ca increased and iPTH gradually decreased with TPTD treatment. Serum OPG levels remained unchanged, while RANKL increased gradually during the study (<jats:italic>P<\/jats:italic>&lt;0.001). There was no correlation between OPG or RANKL and BMD changes or iPTH levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TPTD therapy in women with postmenopausal osteoporosis results in acute increase in serum RANKL levels but does not affect serum OPG. These changes may reflect an increase in the number of active osteoblasts with therapy and might be responsible for the acceleration of bone turnover rate that characterizes TPTD.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-07-0528","type":"journal-article","created":{"date-parts":[[2008,2,25]],"date-time":"2008-02-25T20:44:10Z","timestamp":1203972250000},"page":"411-415","update-policy":"http:\/\/dx.doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":16,"title":["Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-\u03baB ligand levels in women with established osteoporosis treated with teriparatide"],"prefix":"10.1530","volume":"158","author":[{"given":"Athanasios D","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Dimirtios G","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"Stergios A","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Spiridon","family":"Gerou","sequence":"additional","affiliation":[]},{"given":"Vasiliki","family":"Pavlidou","sequence":"additional","affiliation":[]},{"given":"George","family":"Koukoulis","sequence":"additional","affiliation":[]},{"given":"Avraam","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"416","container-title":["European Journal of Endocrinology"],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/158\/3\/411.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T06:16:17Z","timestamp":1535436977000},"score":1.0,"issued":{"date-parts":[[2008,3]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"http:\/\/dx.doi.org\/10.1530\/eje-07-0528","ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T17:03:30Z","timestamp":1574355810166},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2008,3,8]],"date-time":"2008-03-08T00:00:00Z","timestamp":1204934400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00432-008-0373-7","type":"journal-article","created":{"date-parts":[[2008,3,7]],"date-time":"2008-03-07T08:57:32Z","timestamp":1204880252000},"page":"953-960","source":"Crossref","is-referenced-by-count":51,"title":["Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules"],"prefix":"10.1007","volume":"134","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Marina","family":"\u039aita","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Pavlos","family":"Poulakos","sequence":"additional","affiliation":[]},{"given":"Aristidis","family":"Slavakis","sequence":"additional","affiliation":[]},{"given":"Danae","family":"Sofianou","sequence":"additional","affiliation":[]},{"given":"Nikolaos","family":"Flaris","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Leontsini","sequence":"additional","affiliation":[]},{"given":"Anargyros","family":"Kourtis","sequence":"additional","affiliation":[]},{"given":"Avraam","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,3,8]]},"reference":[{"key":"373_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/acta.0.1210197","volume":"121","author":"A Belfiore","year":"1989","unstructured":"Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R, Filetti S (1989) High frequency of cancer in cold thyroid nodules occurring at young age. Acta Endocrinol (Copenh) 121:197\u2013202","journal-title":"Acta Endocrinol (Copenh)"},{"key":"373_CR2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(92)90164-7","volume":"93","author":"A Belfiore","year":"1992","unstructured":"Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93:363\u2013369","journal-title":"Am J Med"},{"key":"373_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0002-9610(83)90262-3","volume":"146","author":"MA Block","year":"1983","unstructured":"Block MA, Dailey GE, Robb JA (1983) Thyroid nodules indeterminate by needle biopsy. Am J Surg 146:72\u201378","journal-title":"Am J Surg"},{"key":"373_CR4","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/jc.2006-0527","volume":"91","author":"K Boelaert","year":"2006","unstructured":"Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295\u20134301","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1210\/jcem-51-4-915","volume":"51","author":"P Carayon","year":"1980","unstructured":"Carayon P, Thomas-Morvan C, Castanas E, Tubiana M (1980) Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. J Clin Endocrinol Metab 51:915\u2013920","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1088\/0952-4746\/26\/2\/001","volume":"26","author":"E Cardis","year":"2006","unstructured":"Cardis E, Howe G, Ron E, Bebeshko V, Bogdanova T, Bouville A, Carr Z, Chumak V, Davis S, Demidchik Y, Drozdovitch V, Gentner N, Gudzenko N, Hatch M, Ivanov V, Jacob P, Kapitonova E, Kenigsberg Y, Kesminiene A, Kopecky KJ, Kryuchkov V, Loos A, Pinchera A, Reiners C, Repacholi M, Shibata Y, Shore RE, Thomas G, Tirmarche M, Yamashita S, Zvonova I (2006) Cancer consequences of the Chernobyl accident: 20\u00a0years on. J Radiol Prot 26:127\u2013140","journal-title":"J Radiol Prot"},{"key":"373_CR7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-142-11-200506070-00011","volume":"142","author":"MR Castro","year":"2005","unstructured":"Castro MR, Gharib H (2005) Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926\u2013931","journal-title":"Ann Intern Med"},{"key":"373_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2265.1988.tb03696.x","volume":"29","author":"TC Chang","year":"1988","unstructured":"Chang TC, Kuo SH, Liaw KY, Chang CC, Chen FW (1988) Cell kinetics, DNA content and TSH receptor\u2013adenylate cyclase system in differentiated thyroid cancer. Clin Endocrinol (Oxf) 29:477\u2013484","journal-title":"Clin Endocrinol (Oxf)"},{"key":"373_CR9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/10507250152740993","volume":"11","author":"LS Chow","year":"2001","unstructured":"Chow LS, Gharib H, Goellner JR, van Heerden JA (2001) Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid 11:1147\u20131151","journal-title":"Thyroid"},{"key":"373_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","volume":"16","author":"DS Cooper","year":"2006","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109\u2013142","journal-title":"Thyroid"},{"key":"373_CR11","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1001\/archinte.1994.00420160075010","volume":"154","author":"S Ezzat","year":"1994","unstructured":"Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838\u20131840","journal-title":"Arch Intern Med"},{"key":"373_CR12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bmj.307.6898.240","volume":"307","author":"JA Franklyn","year":"1993","unstructured":"Franklyn JA, Daykin J, Young J, Oates GD, Sheppard MC (1993) Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 307:240\u2013240","journal-title":"BMJ"},{"key":"373_CR13","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.2006-0690","volume":"91","author":"MC Frates","year":"2006","unstructured":"Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen PR, Marqusee E, Alexander EK (2006) Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 91:3411\u20133417","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF03348005","volume":"20","author":"RV Garcia-Mayor","year":"1997","unstructured":"Garcia-Mayor RV, Perez Mendez LF, Paramo C, Luna CR, Rego IA, Regal M, Sierra JM, Fluiters E (1997) Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice. J Endocrinol Invest 20:482\u2013487","journal-title":"J Endocrinol Invest"},{"key":"373_CR15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.7326\/0003-4819-118-4-199302150-00007","volume":"118","author":"H Gharib","year":"1993","unstructured":"Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282\u2013289","journal-title":"Ann Intern Med"},{"key":"373_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-101-1-25","volume":"101","author":"H Gharib","year":"1984","unstructured":"Gharib H, Goellner JR, Zinsmeister AR, Grant CS, Van Heerden JA (1984) Fine-needle aspiration biopsy of the thyroid: the problem of suspicious cytologic findings. Ann Intern Med 101:25\u201328","journal-title":"Ann Intern Med"},{"key":"373_CR17","first-page":"35","volume":"24","author":"RC Goldberg","year":"1964","unstructured":"Goldberg RC, Lindsay S, Nichols CW, Chaikoff IL (1964) Induction of neoplasms in thyroid glands of rats by subtotal thyroidectomy and by the injection of one microcurie of I-131. Cancer Res 24:35\u201343","journal-title":"Cancer Res"},{"key":"373_CR18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20\u201337","journal-title":"Oncologist"},{"key":"373_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0889-8529(05)70190-0","volume":"30","author":"L Hegedus","year":"2001","unstructured":"Hegedus L (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339\u2013360","journal-title":"Endocrinol Metab Clin North Am"},{"key":"373_CR20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMcp031436","volume":"351","author":"L Hegedus","year":"2004","unstructured":"Hegedus L (2004) Clinical practice: the thyroid nodule. N Engl J Med 351:1764\u20131771","journal-title":"N Engl J Med"},{"key":"373_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0016","volume":"24","author":"L Hegedus","year":"2003","unstructured":"Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102\u2013132","journal-title":"Endocr Rev"},{"key":"373_CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2004.02043.x","volume":"60","author":"WB Kim","year":"2004","unstructured":"Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK (2004) Ultrasonographic screening for detection of thyroid cancer in patients with Graves\u2019 disease. Clin Endocrinol (Oxf) 60:719\u2013725","journal-title":"Clin Endocrinol (Oxf)"},{"key":"373_CR23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/105072502761016502","volume":"12","author":"N Knudsen","year":"2002","unstructured":"Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879\u2013888","journal-title":"Thyroid"},{"key":"373_CR24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","volume":"48","author":"SH Landis","year":"1998","unstructured":"Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6\u201329","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 4","key":"373_CR25","first-page":"23","volume":"106","author":"K Mann","year":"1998","unstructured":"Mann K (1998) Evaluation of risk in autonomously functioning thyroid nodules. Exp Clin Endocrinol Diabetes 106 Suppl 4:23\u201326","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"373_CR26","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-133-9-200011070-00011","volume":"133","author":"E Marqusee","year":"2000","unstructured":"Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696\u2013700","journal-title":"Ann Intern Med"},{"key":"373_CR27","first-page":"1128","volume":"100","author":"A McCall","year":"1986","unstructured":"McCall A, Jarosz H, Lawrence AM, Paloyan E (1986) The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 100:1128\u20131132","journal-title":"Surgery"},{"key":"373_CR28","first-page":"444","volume":"54","author":"C McHenry","year":"1988","unstructured":"McHenry C, Smith M, Lawrence AM, Jarosz H, Paloyan E (1988) Nodular thyroid disease in children and adolescents: a high incidence of carcinoma. Am Surg 54:444\u2013447","journal-title":"Am Surg"},{"key":"373_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03345537","volume":"28","author":"S Morganti","year":"2005","unstructured":"Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, Maggio M, Valenti G, Ceresini G (2005) Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest 28:101\u2013104","journal-title":"J Endocrinol Invest"},{"key":"373_CR30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787\u2013803","journal-title":"Eur J Endocrinol"},{"key":"373_CR31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/jcem.83.3.4615","volume":"83","author":"E Papini","year":"1998","unstructured":"Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780\u2013783","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14310\/horm.2002.111107","volume":"6","author":"SA Polyzos","year":"2007","unstructured":"Polyzos SA, Kita M, Avramidis A (2007) Thyroid nodules\u2014stepwise diagnosis and management. Hormones (Athens) 6:101\u2013119","journal-title":"Hormones (Athens)"},{"key":"373_CR33","first-page":"4318","volume":"81","author":"P Pujol","year":"1996","unstructured":"Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C (1996) Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318\u20134323","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1089\/thy.2004.14.926","volume":"14","author":"C Reiners","year":"2004","unstructured":"Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926\u2013932","journal-title":"Thyroid"},{"key":"373_CR35","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1210\/jc.2006-1772","volume":"91","author":"DS Ross","year":"2006","unstructured":"Ross DS (2006) Editorial: predicting thyroid malignancy. J Clin Endocrinol Metab 91:4253\u20134255","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR36","first-page":"4020","volume":"82","author":"AB Schneider","year":"1997","unstructured":"Schneider AB, Bekerman C, Leland J, Rosengarten J, Hyun H, Collins B, Shore-Freedman E, Gierlowski TC (1997) Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 82:4020\u20134027","journal-title":"J Clin Endocrinol Metab"},{"key":"373_CR37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.2000.10.235","volume":"10","author":"SR Tollin","year":"2000","unstructured":"Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, Perlmutter S (2000) The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10:235\u2013241","journal-title":"Thyroid"},{"key":"373_CR38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","volume":"7","author":"WM Tunbridge","year":"1977","unstructured":"Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481\u2013493","journal-title":"Clin Endocrinol (Oxf)"},{"key":"373_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/thy.1998.8.377","volume":"8","author":"RM Tuttle","year":"1998","unstructured":"Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377\u2013383","journal-title":"Thyroid"},{"key":"373_CR40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-69-3-537","volume":"69","author":"JB Vander","year":"1968","unstructured":"Vander JB, Gaston EA, Dawber TR (1968) The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 69:537\u2013540","journal-title":"Ann Intern Med"},{"key":"373_CR41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archinte.1984.00350150058018","volume":"144","author":"EE Werk","year":"1984","unstructured":"Werk EE, Vernon BM, Gonzalez JJ, Ungaro PC, McCoy RC (1984) Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 144:474\u2013476","journal-title":"Arch Intern Med"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-008-0373-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-008-0373-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:39:47Z","timestamp":1559083187000},"score":1.0,"issued":{"date-parts":[[2008,3,8]]},"references-count":41,"journal-issue":{"published-print":{"date-parts":[[2008,9]]},"issue":"9"},"alternative-id":["373"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00432-008-0373-7","relation":{"cites":[]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T18:25:52Z","timestamp":1574360752544},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1055\/s-2008-1046787","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T14:40:24Z","timestamp":1206974424000},"page":"281-285","source":"Crossref","is-referenced-by-count":17,"title":["Serum Osteoprotegerin and RANKL are not Specifically Altered in Women with Postmenopausal Osteoporosis Treated with Teriparatide or Risedronate: A Randomized, Controlled Trial"],"prefix":"10.1055","volume":"40","author":[{"given":"A.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"D.","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"S.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"S.","family":"Gerou","sequence":"additional","affiliation":[]},{"given":"G.","family":"Koukoulis","sequence":"additional","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]},{"given":"A.","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"194","container-title":["Hormone and Metabolic Research"],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-2008-1046787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T21:16:28Z","timestamp":1495487788000},"score":1.0,"issued":{"date-parts":[[2008,4]]},"references-count":0,"journal-issue":{"published-print":{"date-parts":[[2008,4]]},"issue":"4"},"URL":"http:\/\/dx.doi.org\/10.1055\/s-2008-1046787","ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T20:44:07Z","timestamp":1574369047933},"reference-count":39,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1507\/endocrj.k07e-055","type":"journal-article","created":{"date-parts":[[2008,5,12]],"date-time":"2008-05-12T05:50:25Z","timestamp":1210571425000},"page":"351-357","source":"Crossref","is-referenced-by-count":3,"title":["Sustained Clinical Inactivity and Stabilization of GH\/IGF-1 Levels in an Acromegalic Patient after Discontinuation of Somatostatin Analogue Treatment"],"prefix":"10.1507","volume":"55","author":[{"given":"Avraam","family":"AVRAMIDIS","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"POLYZOS","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"EFSTATHIADOU","sequence":"additional","affiliation":[]},{"given":"Marina","family":"KITA","sequence":"additional","affiliation":[]}],"member":"386","container-title":["Endocrine Journal"],"language":"en","deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T07:57:36Z","timestamp":1557561456000},"score":1.0,"issued":{"date-parts":[[2008]]},"references-count":39,"journal-issue":{"published-print":{"date-parts":[[2008]]},"issue":"2"},"URL":"http:\/\/dx.doi.org\/10.1507\/endocrj.k07e-055","ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T22:58:23Z","timestamp":1574377103393},"reference-count":5,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1507\/endocrj.k07e-123","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T05:52:25Z","timestamp":1214977945000},"page":"613-616","source":"Crossref","is-referenced-by-count":7,"title":["Endogenous Intact PTH is Suppressed during Teriparatide (rhPTH 1-34) Administration in Postmenopausal Women with Established Osteoporosis"],"prefix":"10.1507","volume":"55","author":[{"given":"Athanasios D.","family":"ANASTASILAKIS","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"POLYZOS","sequence":"additional","affiliation":[]},{"given":"Dimitrios G.","family":"GOULIS","sequence":"additional","affiliation":[]},{"given":"Aristides","family":"SLAVAKIS","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"EFSTATHIADOU","sequence":"additional","affiliation":[]},{"given":"Marina","family":"KITA","sequence":"additional","affiliation":[]},{"given":"George","family":"KOUKOULIS","sequence":"additional","affiliation":[]},{"given":"Avraam","family":"AVRAMIDIS","sequence":"additional","affiliation":[]}],"member":"386","container-title":["Endocrine Journal"],"language":"en","deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T12:39:23Z","timestamp":1557664763000},"score":1.0,"issued":{"date-parts":[[2008]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2008]]},"issue":"3"},"URL":"http:\/\/dx.doi.org\/10.1507\/endocrj.k07e-123","ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T23:23:43Z","timestamp":1574465023213},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>Co-existence of primary hyperparathyroidism (PHPT) and non-medullary thyroid carcinoma has been previously reported in sporadic case reports and some surgical series, but the majority of cases concerned women with occult papillary carcinomas without cervical lymph node involvement. We present a 71-year man with PHPT and multinodular goiter who was subjected to surgery for single parathyroid adenoma and was found to have synchronous multifocal papillary thyroid carcinoma (PTC) with cervical lymph node involvement. Review of the literature retrieved only a few similar cases. Ultrasonography of both thyroid and parathyroid glands might be considered in patients with hyperparathyroidism. Given that there are no specific guidelines for the management of patients with synchronous PHPT and PTC, they should be managed like the cases of single PTC.<\/jats:p>","DOI":"10.1590\/s0004-27302010000600012","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:06:18Z","timestamp":1284595578000},"page":"578-582","source":"Crossref","is-referenced-by-count":3,"title":["Primary hyperparathyroidism and incidental multifocal metastatic papillary thyroid carcinoma in a man"],"prefix":"10.1590","volume":"54","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"Aristotle University of Thessaloniki, Greece"}]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[{"name":"Military Hospital, Greece"}]},{"given":"Ioannis P.","family":"Iakovou","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki, Greece"}]},{"given":"Valassia","family":"Partsalidou","sequence":"additional","affiliation":[{"name":"Papanikolaou Hospital, Greece"}]}],"member":"530","reference":[{"issue":"9684","key":"ref1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser WD.","year":"2009","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"94","key":"ref2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","author":"Bilezikian JP","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14310\/horm.2002.111107","article-title":"Thyroid nodules - Stepwise diagnosis and management","volume":"2007","author":"Polyzos SA","journal-title":"Hormones","ISSN":"http:\/\/id.crossref.org\/issn\/0018-5051","issn-type":"print"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/thy.2008.0421","article-title":"Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental","volume":"19","author":"Alevizaki M","year":"2009","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies L","year":"2006","journal-title":"JAMA."},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper DS","year":"2009","journal-title":"Thyroid."},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1611::AID-CNCR26>3.0.CO;2-#","article-title":"Thyroid carcinoma found at parathyroidectomy: association with primary, secondary, and tertiary hyperparathyroidism","volume":"79","author":"Burmeister LA","year":"1997","journal-title":"Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0008-543X","issn-type":"print"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bone.2006.01.146","article-title":"Primary hyperparathyroidism and malignancy: \"studies by nature\"","volume":"39","author":"Cinamon U","year":"2006","journal-title":"Bone","ISSN":"http:\/\/id.crossref.org\/issn\/8756-3282","issn-type":"print"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0002-9610(82)90095-2","article-title":"Primary hyperparathyroidism and nonmedullary thyroid cancer","volume":"143","author":"Linos DA","year":"1982","journal-title":"Am J Surg."},{"issue":"9","key":"ref10","first-page":"685","article-title":"Association of primary hyperparathyroidism and non-medullary thyroid cancer","volume":"162","author":"Krause UC","year":"1996","journal-title":"Eur J Surg."},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0039-6109(16)41733-0","article-title":"Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules","volume":"59","author":"Nishiyama RH","year":"1979","journal-title":"Surg Clin North Am."},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/105072502321085207","article-title":"Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism?","volume":"12","author":"Bentrem DJ","year":"2002","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hed.2880150105","article-title":"Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases","volume":"15","author":"Attie JN","year":"1993","journal-title":"Head Neck."},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4158\/EP09138.OR","article-title":"Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism","volume":"16","author":"Gul K","year":"2010","journal-title":"Endocr Pract."},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2006.0182","article-title":"Preoperative evaluation of thyroid pathology in patients with primary hyperparathyroidism","volume":"17","author":"Ogawa T","year":"2007","journal-title":"Thyroid","ISSN":"http:\/\/id.crossref.org\/issn\/1050-7256","issn-type":"print"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcp\/90.1.72","article-title":"Occult carcinomas of the thyroid: Evaluation of 1,020 sequential autopsies","volume":"90","author":"Lang W","year":"1988","journal-title":"Am J Clin Pathol."},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O","article-title":"Occult carcinoma of the thyroid: A systematic autopsy study from Spain of two series performed with two different methods","volume":"71","author":"Martinez-Tello FJ","year":"1993","journal-title":"Cancer."},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4158\/EP.13.4.380","article-title":"Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism","volume":"13","author":"Lee JK","year":"2007","journal-title":"Endocr Pract."},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archsurg.1978.01370150057010","article-title":"Coexistent parathyroid adenomas and thyroid carcinoma: Can radiation be blamed?","volume":"113","author":"LiVolsi VA","year":"1978","journal-title":"Arch Surg."},{"issue":"11","key":"ref20","first-page":"1707","article-title":"Combined parathyroid adenoma and an occult papillary carcinoma","volume":"25","author":"Meshikhes AW","year":"2004","journal-title":"Saudi Med J."},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1507\/endocrj.45.61","article-title":"Hyperfunctioning thyroid adenoma concomitant with papillary thyroid carcinoma, follicular thyroid adenoma and primary hyperparathyroidism","volume":"45","author":"Sato Y","year":"1998","journal-title":"Endocr J."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1186\/1757-1626-2-9121","article-title":"Synchronous parathyroid adenoma and thyroid papillary carcinoma: a case report","volume":"2","author":"Iakovou IP","year":"2009","journal-title":"Cases J."},{"issue":"6","key":"ref23","first-page":"447","article-title":"Non-medullary thyroid carcinoma in patients with parathyroid adenoma","volume":"142","author":"Kairaluoma MI","year":"1976","journal-title":"Acta Chir Scand."},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2008-1080922","article-title":"The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules","volume":"117","author":"Polyzos SA","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes."}],"container-title":["Arquivos Brasileiros de Endocrinologia & Metabologia"],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v54n6\/12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T20:31:48Z","timestamp":1559680308000},"score":1.0,"issued":{"date-parts":[[2010,8]]},"references-count":24,"journal-issue":{"published-print":{"date-parts":[[2010,8]]},"issue":"6"},"alternative-id":["S0004-27302010000600012"],"URL":"http:\/\/dx.doi.org\/10.1590\/s0004-27302010000600012","relation":{"cites":[]},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T17:20:43Z","timestamp":1574702443747},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00774-015-0687-x","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T06:34:04Z","timestamp":1434004444000},"page":"447-456","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Kokkoris","sequence":"additional","affiliation":[]},{"given":"Grigorios T.","family":"Sakellariou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"687_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","volume":"28","author":"M Lazo","year":"2008","unstructured":"Lazo M, Clark JM (2008) The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 28:339\u2013350","journal-title":"Semin Liver Dis"},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299\u2013314","journal-title":"Curr Mol Med"},{"key":"687_CR3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174\u20131197","journal-title":"Hepatology"},{"key":"687_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2036.2012.05196.x","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y (2012) Review article: non-alcoholic fatty liver disease and osteoporosis-clinical and molecular crosstalk. Aliment Pharmacol Ther 36:345\u2013352","journal-title":"Aliment Pharmacol Ther"},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","volume":"19","author":"G Musso","year":"2013","unstructured":"Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F (2013) Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol Med 19:522\u2013535","journal-title":"Trends Mol Med"},{"key":"687_CR6","first-page":"396545","volume":"2013","author":"R Cui","year":"2013","unstructured":"Cui R, Sheng H, Rui XF, Cheng XY, Sheng CJ, Wang JY, Qu S (2013) Low bone mineral density in chinese adults with nonalcoholic fatty liver disease. Int J Endocrinol 2013:396545","journal-title":"Int J Endocrinol"},{"key":"687_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MED.0b013e32834afff2","volume":"18","author":"AD Anastasilakis","year":"2011","unstructured":"Anastasilakis AD, Polyzos SA, Toulis KA (2011) Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge. Curr Opin Endocrinol Diabetes Obes 18:383\u2013388","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"687_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00774-013-0451-z","volume":"31","author":"HP Bhattoa","year":"2013","unstructured":"Bhattoa HP, Wamwaki J, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P (2013) Serum sclerostin levels in healthy men over 50\u00a0years of age. J Bone Miner Metab 31:579\u2013584","journal-title":"J Bone Miner Metab"},{"key":"687_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132","journal-title":"Calcif Tissue Int"},{"key":"687_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2013.05.010","volume":"56","author":"G Hampson","year":"2013","unstructured":"Hampson G, Edwards S, Conroy S, Blake GM, Fogelman I, Frost ML (2013) The relationship between inhibitors of the Wnt signalling pathway (dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Bone 56:42\u201347","journal-title":"Bone"},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","volume":"11","author":"A Gaudio","year":"2014","unstructured":"Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE (2014) The relationship between inhibitors of the Wnt signalling pathway (sclerostin and dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diabetes Vasc Dis Res 11:48\u201352","journal-title":"Diabetes Vasc Dis Res"},{"key":"687_CR12","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/me.2007-0259","volume":"21","author":"SC Manolagas","year":"2007","unstructured":"Manolagas SC, Almeida M (2007) Gone with the Wnts: \u03b2-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol 21:2605\u20132614","journal-title":"Mol Endocrinol"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","volume":"315","author":"A Mani","year":"2007","unstructured":"Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278\u20131282","journal-title":"Science"},{"key":"687_CR14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jgh.12106","volume":"28","author":"MM Smits","year":"2013","unstructured":"Smits MM, Ioannou GN, Boyko EJ, Utzschneider KM (2013) Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J Gastroenterol Hepatol 28:664\u2013670","journal-title":"J Gastroenterol Hepatol"},{"key":"687_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/1354750X.2013.838305","volume":"18","author":"SA Polyzos","year":"2013","unstructured":"Polyzos SA, Kountouras J, Slavakis A, Zafeiriadou E, Patsiaoura K, Katsiki E, Zavos C, Papatheodorou A, Terpos E (2013) A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study. Biomarkers 18:607\u2013613","journal-title":"Biomarkers"},{"key":"687_CR16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"687_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"687_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63:161\u2013167","journal-title":"Metabolism"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00774-013-0524-z","volume":"32","author":"Y Rhee","year":"2014","unstructured":"Rhee Y, Kim WJ, Han KJ, Lim SK, Kim SH (2014) Effect of liver dysfunction on circulating sclerostin. J Bone Miner Metab 32:542\u2013549","journal-title":"J Bone Miner Metab"},{"key":"687_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/alcalc\/ags136","volume":"48","author":"E Gonz\u00e1lez-Reimers","year":"2013","unstructured":"Gonz\u00e1lez-Reimers E, Mart\u00edn-Gonz\u00e1lez C, de la Vega-Prieto MJ, Pelazas-Gonz\u00e1lez R, Fern\u00e1ndez-Rodr\u00edguez C, L\u00f3pez-Prieto J, Alvisa-Negr\u00edn J, Santolaria-Fern\u00e1ndez F (2013) Serum sclerostin in alcoholics: a pilot study. Alcohol Alcohol 48:278\u2013282","journal-title":"Alcohol Alcohol"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.11005\/jbm.2014.21.1.69","volume":"21","author":"E Gonz\u00e1lez-Reimers","year":"2014","unstructured":"Gonz\u00e1lez-Reimers E, L\u00f3pez-Prieto J, Pelazas-Gonz\u00e1lez R, Alem\u00e1n-Valls MR, Jos\u00e9 de la Vega-Prieto M, Jorge-Ripper C, Dur\u00e1n-Castell\u00f3n MC, Santolaria-Fern\u00e1ndez F (2014) Serum sclerostin in hepatitis C virus infected patients. J Bone Metab 21:69\u201375","journal-title":"J Bone Metab"},{"key":"687_CR22","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","volume":"25","author":"R Sapir-Koren","year":"2014","unstructured":"Sapir-Koren R, Livshits G (2014) Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption\u2013formation cycles? Osteoporos Int 25:2685\u20132700","journal-title":"Osteoporos Int"},{"key":"687_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0736-0266(02)00161-4","volume":"21","author":"K Okazaki","year":"2003","unstructured":"Okazaki K, Jingushi S, Ikenoue T, Urabe K, Sakai H, Iwamoto Y (2003) Expression of parathyroid hormone-related peptide and insulin-like growth factor I during rat fracture healing. J Orthop Res 21:511\u2013520","journal-title":"J Orthop Res"},{"key":"687_CR24","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.00092.2013","volume":"305","author":"KH Lau","year":"2013","unstructured":"Lau KH, Baylink DJ, Zhou XD, Rodriguez D, Bonewald LF, Li Z, Ruffoni D, M\u00fcller R, Kesavan C, Sheng MH (2013) Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity. Am J Physiol Endocrinol Metab 305:E271\u2013E281","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"687_CR25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jbmr.5650110916","volume":"11","author":"DM Thomas","year":"1996","unstructured":"Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD (1996) Insulin receptor expression in bone. J Bone Miner Res 11:1312\u20131320","journal-title":"J Bone Miner Res"},{"key":"687_CR26","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1210\/jc.2013-1402","volume":"98","author":"AD Anastasilakis","year":"2013","unstructured":"Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P (2013) Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. J Clin Endocrinol Metab 98:3206\u20133212","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46:272\u2013284","journal-title":"J Clin Gastroenterol"},{"key":"687_CR28","author":"S Lattanzio","year":"2014","unstructured":"Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, Formoso G, Consoli A, Aukrust P, Davi G (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc. doi: 10.1161\/JAHA.114.001000","journal-title":"J Am Heart Assoc","DOI":"10.1161\/JAHA.114.001000","doi-asserted-by":"publisher"},{"key":"687_CR29","doi-asserted-by":"crossref","first-page":"e111703","DOI":"10.1371\/journal.pone.0111703","volume":"9","author":"A Garcia-Martin","year":"2014","unstructured":"Garcia-Martin A, Reyes-Garcia R, Garcia-Fontana B, Morales-Santana S, Coto-Montes A, Munoz-Garach M, Rozas-Moreno P, Munoz-Torres M (2014) Relationship of dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PLoS One 9:e111703","journal-title":"PLoS One"},{"key":"687_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2009.09.003","volume":"38","author":"JL Freese","year":"2010","unstructured":"Freese JL, Pino D, Pleasure SJ (2010) Wnt signaling in development and disease. Neurobiol Dis 38:148\u2013153","journal-title":"Neurobiol Dis"},{"key":"687_CR31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s13277-014-2750-y","volume":"36","author":"L Liang","year":"2015","unstructured":"Liang L, He H, Lv R, Zhang M, Huang H, An Z, Li S (2015) Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma. Tumour Biol 36:1245\u20131250","journal-title":"Tumour Biol"},{"key":"687_CR32","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","volume":"128","author":"J Ertle","year":"2011","unstructured":"Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, Schlaak JF, Gerken G, Syn WK, Canbay A (2011) Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 128:2436\u20132443","journal-title":"Int J Cancer"},{"key":"687_CR33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5301\/jbm.5000015","volume":"28","author":"H Yang","year":"2013","unstructured":"Yang H, Chen GD, Fang F, Liu Z, Lau SH, Zhang JF, Lau WY, Yang LY (2013) Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. Int J Biol Markers 28:286\u2013297","journal-title":"Int J Biol Markers"},{"key":"687_CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","volume":"42","author":"SS Moon","year":"2012","unstructured":"Moon SS, Lee YS, Kim SW (2012) Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42:423\u2013429","journal-title":"Endocrine"},{"key":"687_CR35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2036.2011.04924.x","volume":"35","author":"PE Pardee","year":"2012","unstructured":"Pardee PE, Dunn W, Schwimmer JB (2012) Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther 35:248\u2013254","journal-title":"Aliment Pharmacol Ther"},{"key":"687_CR36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y, Dai M, Chen Y, Lu J, Liu J, Bi Y, Ning G (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97:2033\u20132038","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00508-012-0211-4","volume":"124","author":"T Purnak","year":"2012","unstructured":"Purnak T, Beyazit Y, Ozaslan E, Efe C, Hayretci M (2012) The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 124:526\u2013531","journal-title":"Wien Klin Wochenschr"},{"key":"687_CR38","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4254\/wjh.v5.i11.627","volume":"5","author":"M Kaya","year":"2013","unstructured":"Kaya M, I\u015f\u0131k D, Be\u015fta\u015f R, Evliyao\u011flu O, Akpolat V, B\u00fcy\u00fckbayram H, Kaplan MA (2013) Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 5:627\u2013634","journal-title":"World J Hepatol"},{"key":"687_CR39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","volume":"23","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide. Osteoporos Int 23:1171\u20131176","journal-title":"Osteoporos Int"},{"key":"687_CR40","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/jc.2014-2327","volume":"99","author":"J Paccou","year":"2014","unstructured":"Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P, Massy ZA, Brazier M, Kamel S (2014) The relationships between serum sclerostin, bone mineral density and vascular calcification in rheumatoid arthritis. J Clin Endocrinol Metab 99:4740\u20134748","journal-title":"J Clin Endocrinol Metab"},{"key":"687_CR41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0032-1312618","volume":"44","author":"E Voskaridou","year":"2012","unstructured":"Voskaridou E, Christoulas D, Plata E, Bratengeier C, Anastasilakis AD, Komninaka V, Kaliontzi D, Gkotzamanidou M, Polyzos SA, Dimopoulou M, Terpos E (2012) High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density. Horm Metab Res 44:909\u2013913","journal-title":"Horm Metab Res"},{"key":"687_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12020-012-9748-2","volume":"42","author":"G Musso","year":"2012","unstructured":"Musso G (2012) Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine 42:237\u2013239","journal-title":"Endocrine"}],"container-title":["Journal of Bone and Mineral Metabolism"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0687-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0687-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T16:29:23Z","timestamp":1566836963000},"score":1.0,"issued":{"date-parts":[[2015,6,9]]},"references-count":42,"journal-issue":{"published-print":{"date-parts":[[2016,7]]},"issue":"4"},"alternative-id":["687"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-015-0687-x","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T01:15:37Z","timestamp":1574730937955},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00125-015-3769-3","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T22:10:24Z","timestamp":1443219024000},"page":"30-43","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Konstantinos N.","family":"Aronis","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Dimitrios D.","family":"Raptis","sequence":"additional","affiliation":[]},{"given":"Maria F.","family":"Vasiloglou","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"key":"3769_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299\u2013314","journal-title":"Curr Mol Med"},{"key":"3769_CR2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274\u2013285","journal-title":"Aliment Pharmacol Ther"},{"key":"3769_CR3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","volume":"152","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93\u2013100","journal-title":"Ann Intern Med"},{"key":"3769_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"Moon HS, Dalamaga M, Kim SY et al (2013) Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 34:377\u2013412","journal-title":"Endocr Rev"},{"key":"3769_CR5","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","volume":"301","author":"CS Mantzoros","year":"2011","unstructured":"Mantzoros CS, Magkos F, Brinkoetter M et al (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567\u2013E584","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3769_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","volume":"18","author":"M Dalamaga","year":"2013","unstructured":"Dalamaga M, Chou SH, Shields K, Papageorgiou P, Polyzos SA, Mantzoros CS (2013) Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell Metab 18:29\u201342","journal-title":"Cell Metab"},{"key":"3769_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MCG.0b013e3181ec5c66","volume":"45","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2011) The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of literature. J Clin Gastroenterol 45:50\u201354","journal-title":"J Clin Gastroenterol"},{"key":"3769_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","volume":"16","author":"K Imajo","year":"2012","unstructured":"Imajo K, Fujita K, Yoneda M et al (2012) Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 16:44\u201354","journal-title":"Cell Metab"},{"key":"3769_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2015) Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64:60\u201378","journal-title":"Metabolism"},{"key":"3769_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63:161\u2013167","journal-title":"Metabolism"},{"key":"3769_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Mantzoros CS (2015) Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism 64:5\u201312","journal-title":"Metabolism"},{"key":"3769_CR12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"key":"3769_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","volume":"60","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J (2011) Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 60:313\u2013326","journal-title":"Metabolism"},{"key":"3769_CR14","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474","journal-title":"Am J Gastroenterol"},{"key":"3769_CR15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"3769_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"key":"3769_CR17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jhep.2004.08.020","volume":"41","author":"P Angulo","year":"2004","unstructured":"Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD (2004) Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 41:943\u2013949","journal-title":"J Hepatol"},{"key":"3769_CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11695-009-9912-9","volume":"19","author":"M Argentou","year":"2009","unstructured":"Argentou M, Tiniakos DG, Karanikolas M et al (2009) Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. Obes Surg 19:1313\u20131323","journal-title":"Obes Surg"},{"key":"3769_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1665-2681(19)31856-3","volume":"7","author":"B Canbakan","year":"2008","unstructured":"Canbakan B, Tahan V, Balci H et al (2008) Leptin in nonalcoholic fatty liver disease. Ann Hepatol 7:249\u2013254","journal-title":"Ann Hepatol"},{"key":"3769_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2006.01337.x","volume":"26","author":"A Cayon","year":"2006","unstructured":"Cayon A, Crespo J, Mayorga M, Guerra A, Pons-Romero F (2006) Increased expression of Ob-Rb and its relationship with the overexpression of TGF-\u03b21 and the stage of fibrosis in patients with nonalcoholic steatohepatitis. Liver Int 26:1065\u20131071","journal-title":"Liver Int"},{"key":"3769_CR21","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/j.1572-0241.2003.08767.x","volume":"98","author":"N Chalasani","year":"2003","unstructured":"Chalasani N, Crabb DW, Cummings OW et al (2003) Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 98:2771\u20132776","journal-title":"Am J Gastroenterol"},{"key":"3769_CR22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","volume":"47","author":"M Charlton","year":"2008","unstructured":"Charlton M, Angulo P, Chalasani N et al (2008) Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 47:484\u2013492","journal-title":"Hepatology"},{"key":"3769_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","volume":"36","author":"S Chitturi","year":"2002","unstructured":"Chitturi S, Farrell G, Frost L et al (2002) Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 36:403\u2013409","journal-title":"Hepatology"},{"key":"3769_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","volume":"23","author":"S Dasarathy","year":"2011","unstructured":"Dasarathy S, Yang Y, McCullough AJ, Marczewski S, Bennett C, Kalhan SC (2011) Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol 23:382\u2013388","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3769_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.2047-6310.2012.00082.x","volume":"7","author":"E Fitzpatrick","year":"2012","unstructured":"Fitzpatrick E, Dew TK, Quaglia A, Sherwood RA, Mitry RR, Dhawan A (2012) Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. Pediatr Obes 7:471\u2013479","journal-title":"Pediatr Obes"},{"key":"3769_CR26","first-page":"2422","volume":"46","author":"E Giannini","year":"1999","unstructured":"Giannini E, Botta F, Cataldi A et al (1999) Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 46:2422\u20132425","journal-title":"Hepatogastroenterology"},{"key":"3769_CR27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-079X.2012.01023.x","volume":"54","author":"M Gonciarz","year":"2013","unstructured":"Gonciarz M, Bielanski W, Partyka R et al (2013) Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res 54:154\u2013161","journal-title":"J Pineal Res"},{"key":"3769_CR28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-11-0864","volume":"166","author":"JW Haukeland","year":"2012","unstructured":"Haukeland JW, Dahl TB, Yndestad A et al (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166:503\u2013510","journal-title":"Eur J Endocrinol"},{"key":"3769_CR29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.14.2888","volume":"14","author":"XD Huang","year":"2008","unstructured":"Huang XD, Fan Y, Zhang H et al (2008) Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 14:2888\u20132893","journal-title":"World J Gastroenterol"},{"key":"3769_CR30","first-page":"46","volume":"40","author":"JM Hui","year":"2004","unstructured":"Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46\u201354","journal-title":"Hepatology"},{"key":"3769_CR31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/oby.2009.89","volume":"17","author":"SR Kashyap","year":"2009","unstructured":"Kashyap SR, Diab DL, Baker AR et al (2009) Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring) 17:1696\u20131701","journal-title":"Obesity (Silver Spring)"},{"key":"3769_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","volume":"32","author":"E Koehler","year":"2012","unstructured":"Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M (2012) Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int 32:279\u2013286","journal-title":"Liver Int"},{"key":"3769_CR33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00464-006-9185-5","volume":"21","author":"D Le","year":"2007","unstructured":"Le D, Marks D, Lyle E et al (2007) Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients. Surg Endosc 21:1593\u20131599","journal-title":"Surg Endosc"},{"key":"3769_CR34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1478-3231.2009.02022.x","volume":"29","author":"M Lemoine","year":"2009","unstructured":"Lemoine M, Ratziu V, Kim M et al (2009) Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int 29:1431\u20131438","journal-title":"Liver Int"},{"key":"3769_CR35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/MEG.0b013e32835609b0","volume":"24","author":"MV Machado","year":"2012","unstructured":"Machado MV, Coutinho J, Carepa F, Costa A, Proenca H, Cortez-Pinto H (2012) How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 24:1166\u20131172","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3769_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00592-008-0063-6","volume":"46","author":"M Manco","year":"2009","unstructured":"Manco M, Giordano U, Turchetta A et al (2009) Insulin resistance and exercise capacity in male children and adolescents with non-alcoholic fatty liver disease. Acta Diabetol 46:97\u2013104","journal-title":"Acta Diabetol"},{"key":"3769_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1665-2681(19)31790-9","volume":"8","author":"LE Munoz","year":"2009","unstructured":"Munoz LE, Cordero P, Torres L, Sauceda AY, Flores JP, Segura JJ (2009) Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. Ann Hepatol 8:123\u2013128","journal-title":"Ann Hepatol"},{"key":"3769_CR38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","volume":"42","author":"G Musso","year":"2005","unstructured":"Musso G, Gambino R, Durazzo M et al (2005) Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42:1175\u20131183","journal-title":"Hepatology"},{"key":"3769_CR39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.02288","volume":"155","author":"V Nobili","year":"2006","unstructured":"Nobili V, Manco M, Ciampalini P et al (2006) Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 155:735\u2013743","journal-title":"Eur J Endocrinol"},{"key":"3769_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.01821","volume":"152","author":"C Pagano","year":"2005","unstructured":"Pagano C, Soardo G, Esposito W et al (2005) Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 152:113\u2013118","journal-title":"Eur J Endocrinol"},{"key":"3769_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2036.2011.04929.x","volume":"35","author":"S Petta","year":"2012","unstructured":"Petta S, Amato MC, Di Marco V et al (2012) Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35:238\u2013247","journal-title":"Aliment Pharmacol Ther"},{"key":"3769_CR42","first-page":"772","volume":"107","author":"I Pirvulescu","year":"2012","unstructured":"Pirvulescu I, Gheorghe L, Csiki I et al (2012) Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Chirurgia (Bucur) 107:772\u2013779","journal-title":"Chirurgia (Bucur)"},{"key":"3769_CR43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2013.09.013","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS (2014) Irisin in patients with nonalcoholic fatty liver disease. Metabolism 63:207\u2013217","journal-title":"Metabolism"},{"key":"3769_CR44","first-page":"986","volume":"137","author":"DK Singh","year":"2013","unstructured":"Singh DK, Sakhuja P, Rastogi A, Singh A, Gondal R, Sarin SK (2013) Serum leptin levels correlate with body mass index but not with histologic disease severity in Indian patients with non-alcoholic steatohepatitis: a pilot study. Indian J Med Res 137:986\u2013987","journal-title":"Indian J Med Res"},{"key":"3769_CR45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/iub.597","volume":"64","author":"M Swellam","year":"2012","unstructured":"Swellam M, Hamdy N (2012) Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. IUBMB Life 64:180\u2013186","journal-title":"IUBMB Life"},{"key":"3769_CR46","first-page":"490","volume":"89","author":"R Tungtrongchitr","year":"2006","unstructured":"Tungtrongchitr R, Treeprasertsuk S, Ei NN, Thepouyporn A, Phonrat B, Huntrup A (2006) Serum leptin concentrations in chronic hepatitis. J Med Assoc Thail 89:490\u2013499","journal-title":"J Med Assoc Thail"},{"key":"3769_CR47","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1111\/j.1572-0241.2000.03297.x","volume":"95","author":"A Uygun","year":"2000","unstructured":"Uygun A, Kadayifci A, Yesilova Z et al (2000) Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95:3584\u20133589","journal-title":"Am J Gastroenterol"},{"key":"3769_CR48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","volume":"4","author":"VW Wong","year":"2006","unstructured":"Wong VW, Hui AY, Tsang SW et al (2006) Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4:1154\u20131161","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3769_CR49","doi-asserted-by":"crossref","first-page":"34295","DOI":"10.1155\/MI\/2006\/34295","volume":"2006","author":"M Yalniz","year":"2006","unstructured":"Yalniz M, Bahcecioglu IH, Ataseven H et al (2006) Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis. Mediat Inflamm 2006:34295","journal-title":"Mediat Inflamm"},{"key":"3769_CR50","first-page":"1","volume":"7","author":"M Egger","year":"2003","unstructured":"Egger M, Juni P, Bartlett C, Holenstein F, Sterne J (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 7:1\u201376","journal-title":"Health Technol Assess"}],"container-title":["Diabetologia"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-015-3769-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3769-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:19:31Z","timestamp":1567210771000},"score":1.0,"issued":{"date-parts":[[2015,9,26]]},"references-count":50,"journal-issue":{"published-print":{"date-parts":[[2016,1]]},"issue":"1"},"alternative-id":["3769"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00125-015-3769-3","relation":{"cites":[]},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}]},{"indexed":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T16:34:48Z","timestamp":1575304488818},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"DOI":"10.1055\/s-2008-1058082","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T00:38:40Z","timestamp":1220488720000},"page":"496-500","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiologic Analysis of Thyroid Fine Needle Aspiration Biopsies over a Period of 18 Years (1987\u20132004)"],"prefix":"10.1055","volume":"116","author":[{"given":"S.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"M.","family":"Kita","sequence":"additional","affiliation":[]},{"given":"D.","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"A.","family":"Benos","sequence":"additional","affiliation":[]},{"given":"N.","family":"Flaris","sequence":"additional","affiliation":[]},{"given":"M.","family":"Leontsini","sequence":"additional","affiliation":[]},{"given":"A.","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"194","published-online":{"date-parts":[[2008,4,1]]},"container-title":["Experimental and Clinical Endocrinology & Diabetes"],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-2008-1058082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T11:23:29Z","timestamp":1496834609000},"score":1.0,"issued":{"date-parts":[[2008,4,1]]},"references-count":0,"journal-issue":{"published-online":{"date-parts":[[2008,9,3]]},"published-print":{"date-parts":[[2008,8]]},"issue":"08"},"URL":"http:\/\/dx.doi.org\/10.1055\/s-2008-1058082","ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":["Internal Medicine","Endocrinology, Diabetes and Metabolism","Endocrinology","General Medicine"]}],"items-per-page":30,"query":{"start-index":0,"search-terms":null}}}